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Abstract—In the past decade, there has been a resurgence in6
the field of unobtrusive cardiomechanical assessment, through7
advancing methods for measuring and interpreting ballistocardio-8
gram (BCG) and seismocardiogram (SCG) signals. Novel instru-9
mentation solutions have enabled BCG and SCG measurement10
outside of clinical settings, in the home, in the field, and even in11
microgravity. Customized signal processing algorithms have led to12
reduced measurement noise, clinically relevant feature extraction,13
and signal modeling. Finally, human subjects physiology studies14
have been conducted using these novel instruments and signal pro-15
cessing tools with promising clinically relevant results. This paper16
reviews the recent advances in these areas of modern BCG and17
SCG research.18
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I. INTRODUCTION 22
A S detailed in the following sections, the ballistocardio- 23gram (BCG) is a measurement of the recoil forces of the 24
body in reaction to cardiac ejection of blood into the vascula- 25
ture [1], while the seismocardiogram (SCG) represents the local 26
vibrations of the chest wall in response to the heartbeat [2]. 27
The BCG phenomenon was first observed in 1877 by Gordon, 28
with the finding that, as a subject would stand on a weighing 29
scale, the needle would vibrate synchronously to the subject’s 30
heartbeat [3]. Nearly 60 years later, Starr and colleagues created 31
an instrument in the form of a table with a mobile top surface 32
to measure the BCG in a repeatable scientific manner [1]. The 33
SCG was first observed by Bozhenko in 1961, and was first 34
applied in clinical studies 30 years later in 1991 by Salerno and 35
Zanetti [4]. Throughout the 1900s, both BCG and SCG signals 36
were heavily investigated and several publications appeared in 37
major scientific and clinical journals (e.g., [4]–[7]). However, 38
because of the advent of echocardiography and magnetic res- 39
onance imaging, and overly-cumbersome hardware, BCG and 40
SCG were largely abandoned by the medical community [8]. 41
Today, technological advancements largely simplify the mea- 42
surement and assessment of these signals and open new perspec- 43
tives in their clinical use. This paper reviews the instrumentation 44
and signal processing advances which have helped to propel 45
BCG and SCG into this revival. It also summarizes some of the 46
key human subjects studies performed recently that support the 47
use of BCG and SCG in extra-clinical applications. 48
II. DESCRIPTION OF BCG AND SCG SIGNALS 49
A. BCG Signal Description 50
At every heartbeat, the blood travelling along the vascular tree 51
produces changes in the body center of mass. Body micromove- 52
ments are then produced by the recoil forces to maintain the 53
overall momentum. The BCG is the recording of these move- 54
ments, can be measured as a displacement, velocity, or accelera- 55
tion signal, and is known to include movements in all three axes. 56
The longitudinal BCG is a measure of the head-to-foot deflec- 57
tions of the body, while the transverse BCG represents antero– 58
posterior (or dorso–ventral) vibrations. The original bed- and 59
table-based BCG systems focused on longitudinal BCG mea- 60
surements, representing what was supposed to be the largest 61
projection of the 3-D forces resulting from cardiac ejection 62
[1]. Table I summarizes modern BCG measurement systems 63
and their axes of measurement. Note that for some systems, 64
head-to-foot and dorso–ventral forces are unavoidably, mixed 65
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TABLE I
MODERN BCG SYSTEMS AND THEIR CORRESPONDING MEASUREMENT AXES
Modern BCG System Axis Comments / Challenges
Accel. (0g) All (3-D) - Needs reduced gravity
Accel. (1g) Head-to-foot - Placement affects signal shape
and amplitude
- Motion artifacts must be
detected and mitigated
Bed Head-to-foot or
Dorso-ventral
- Cross-axis coupling
- Changes in sleep position affect
signal quality / shape
Chair Head-to-foot or
Dorso-ventral
- Posture affects signal quality
and repeatability
Weighing Scale Head-to-foot - Posture affects signal quality
and repeatability
- Motion artifacts must be
detected and mitigated
together in the measurement, and this should be accounted for66
when interpreting results. However, in spite of the 3-D nature of67
the BCG, for a long period of time only the microdisplacements68
of the body along the longitudinal axis (head-to-foot) were con-69
sidered. Currently, BCG is mainly measured using a force plate70
or force sensor placed on a weighing scale or under the seat of a71
chair, with the subject in a vertical position. Modern approaches72
to BCG measurement are discussed below in Section III.73
It should be considered, however, that the gravity force and74
any contact of the body with external objects, including the75
floor and measuring devices, somewhat interferes with, or even76
impedes, the body displacement induced by the recoil forces.77
As a result, the BCG measurement on earth is always affected78
by some distortion. The ideal environment for assessing the79
BCG would be in microgravity settings, such as during space80
missions. Such experiments have been performed, and the re-81
sults described below confirm that in microgravity the whole82
body recoil forces (BCG) are significant in all three dimensions83
[9]–[12]. Modeling studies examining the cardiogenic traction84
forces of the aorta have confirmed this finding as well [13].85
B. SCG Signal Description86
SCG is the measure of the thoracic vibrations produced by the87
heart’s contraction and the ejection of blood from the ventricles88
into the vascular tree. Today, the SCG can readily be detected89
by placing a low-noise accelerometer on the chest. If a tri-axial90
accelerometer is used, SCG components are present in all three91
axes, each displaying a specific pattern [12], [14]. However, in92
the literature, the majority of studies on SCG only focus on the93
amplitude of the dorso–ventral component, although it is likely94
that additional biological information could be derived also from95
the analysis of the longitudinal and lateral SCG components, and96
from the analysis of the acceleration vector trajectory during97
the heart cycle. Unless the contrary is stated to be consistent98
with the prevalent literature only the dorso–ventral acceleration99
component of SCG will be considered in the remainder of this100
paper.101
C. BCG and SCG Waveforms102
For each heart contraction, a BCG and SCG waveform is gen-103
erated. Each waveform is characterized by several peaks and val-104
Fig. 1. Simultaneously acquired Lead II electrocardiogram (ECG); three-axis
seismocardiogram (SCG) with z indicating the dorso-ventral axis, x indicating
the right-to-left lateral axis, and y indicating the head-to-foot axis; ballisto-
cardiogram (BCG); impedance cardiogram (ICG); and arterial blood pressure
(ABP) measured at the finger, signals from one subject, illustrating the relative
timing and amplitude features of the signals.
leys reflecting specific events of the beating heart. Fig. 1 shows a 105
typical ECG, head-to-foot BCG, tri-axial SCG, impedance car- 106
diogram (ICG), and arterial blood pressure (ABP) measurement 107
from a healthy subject (data were collected with approval from 108
the Institutional Review Board, IRB, at the Georgia Institute 109
of Technology, and with written informed consent obtained). A 110
high-resolution, miniature accelerometer was used for the SCG 111
data collection (356A32, PCB Piezotronics, Depew, NY, USA), 112
and a modified weighing scale was used for the BCG recording 113
as described previously in [15]. The ECG and ICG waveforms 114
were measured using the BN-RSPEC and BN-NICO wireless 115
units (BIOPAC Systems, Inc., Goleta, CA, USA) interfaced to 116
the MP150WSW data acquisition hardware (BIOPAC Systems, 117
Inc., Goleta, CA, USA). The ABP was measured from the fin- 118
ger using the A2SYS Nexfin Monitor (Edwards Lifesciences, 119
Irvine, CA, USA). For this measurement, z corresponded to the 120
dorso–ventral, y to the head-to-foot, and x to the right-to-left 121
lateral components of the SCG. The labels of the peaks and val- 122
leys of the dorso–ventral components shown in this figure are 123
according to [16], [17]; for the BCG, the labels are according 124
to [1]. For the SCG, the labels correspond to the physiological 125
event they are believed to represent: MC, mitral valve closure; 126
IVC, isovolumetric contraction; AO, aortic valve opening; RE, 127
rapid ejection; AC, aortic valve closure; MO, mitral valve open- 128
ing; and RF, rapid filling. For the BCG, the labels of the waves 129
are not associated directly with underlying events, but rather 130
the current understanding is that the waveform represents the 131
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Fig. 2. Compilation of modern BCG and SCG acquisition hardware. (a) PVDF sensor installed into the bed for BCG measurements during sleep. (b) Tri-axial
SCG measurement system built into the MagIC-SCG vest for continuous recordings during normal activities of daily living. Modified from [14] with permission.
(c) Wearable 3-D BCG measurement hardware (Pneumocard) being used on board a parabolic flight for microgravity BCG measurements; Photo Credit: ESA.
(d) Weighing scale with built in circuitry for BCG measurement from a standing subject. (e) Flexible hardware for chest-mounted tri-axial SCG measurements.
combined mechanical pulse response of the vasculature and132
body to cardiac ejection of blood [18]. Note that, when the133
BCG is measured by a scale or force plate, the SCG and BCG134
units are not the same; the SCG records the accelerations of135
the chest wall, and is thus presented in units of milligram; the136
BCG represents the displacements of the center of mass of137
the subject on the weighing scale, which are then converted138
to units of force by the spring constant for the scale platform,139
and thus it is presented in units of Newtons. The mass that is140
accelerated for the SCG is not the same as the mass acceler-141
ated for the BCG; as such, the direct conversion of the BCG to142
acceleration units or the SCG to force units has not yet been143
elucidated.144
D. Importance of Sensor Location, Axis Selection145
and Orientation146
For both BCG and SCG, the measurement location has a sig-147
nificant bearing on the morphology, amplitude, and clinically148
relevant features of the signal. For the SCG, since it is a mea-149
sure of local vibrations, the precise location of the sensor on150
the chest impacts the measured signal [19]–[21]. A widely used151
placement has been on the sternum [14], [22], [23]. Pandia et al.152
found that the second heart sound was more pronounced when153
the SCG was measured on the left side of the chest compared154
to the sternum [19]. For BCG signals measured using an ac-155
celerometer, the same is true; an accelerometer placed on the156
foot will not measure the same BCG signal as one placed on157
the head, thus stressing the importance of a clear description of,158
and thoughtfulness regarding, the sensor location on the body.159
An additional crucial issue is the orientation of the acceleration 160
axis. BCG or SCG accelerations in the dorso–ventral direction 161
will not be identical to those in the lateral (right-to-left) or head- 162
to-foot direction; consequently, depending on the purpose of 163
the measurement the axis should be chosen accordingly or a 164
three-axis accelerometer should be used. 165
In spite of the major role played by the selection of the mea- 166
surement axes, the axes orientation, and the sensor location, 167
from the review of the existing literature it appears that infor- 168
mation on these aspects is often missing, making difficult the 169
understanding of the experimental setup and the interpretation 170
of results. Thus, as detailed in Section VI, a standardization 171
on these issues is deemed necessary, and in the meantime, it 172
is advisable that the above pieces of information are clearly 173
stated in any scientific communication dealing with BCG and 174
SCG. 175
III. INSTRUMENTATION: ENABLING UBIQUITOUS MONITORING 176
Fig. 2 shows a compilation of photos depicting several exam- 177
ples of modern BCG and SCG acquisition hardware, enabling 178
data acquisition in a variety of settings, including in bed, in 179
the home, outdoors, and in microgravity. These systems are 180
discussed below in detail. 181
A. Wearable BCG or SCG Systems 182
The primary advantage of wearable BCG or SCG mea- 183
surement systems is the possibility of obtaining data contin- 184
uously throughout normal daily living. Additionally, record- 185
ings with wearable systems can potentially be acquired in any 186
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environment; thus, providing an opportunity to assess a per-187
son’s cardiovascular performance under various environmental188
settings or stressors.189
The sensor type used most often for wearable BCG or SCG190
measurements is an accelerometer, typically with three-axis191
measurement capability, that is mechanically coupled to the192
body with either adhesives, plastic mounting, or textiles. In193
2007, Castiglioni et al. tested the SCG assessment by an ex-194
ternal three-axis MEMS accelerometer placed on the left clavi-195
cle, connected to a smart garment with textile ECG electrodes,196
thus obtaining simultaneous tri-axial SCG and single-lead ECG197
recordings [24]. The concept was subsequently refined, and in198
2010, Di Rienzo et al. proposed an integrated vest equipped with199
sensors, the MagIC-SCG device, in which the accelerometer200
was inside the system electronics and placed in contact with the201
subject’s sternum [14]. Through this system, SCG was recorded202
over 24 h in ambulant subjects, while performing a variety of203
activities of normal daily living and beat-to-beat estimates of204
cardiac time intervals (CTIs) could be estimated [21]. Chuo205
et al. developed miniaturized hardware (55× 15× 3 mm) on206
a flexible substrate with adhesive backing for wireless tri-axial207
SCG recording from the sternum (also with a MEMS accelerom-208
eter) together with single-lead ECG and coarse single-point skin209
temperature via a thermistor [25]. Baevsky et al. developed a210
portable system, “Pneumocard,” for the assessment of the car-211
diac function of cosmonauts on board the International Space212
Station [26]. The system comprised a single-axis MEMS ac-213
celerometer placed at the apex of the heart for the recording of214
the SCG signal. Later, a three-axis MEMS accelerometer was215
added to the system for the recording of the BCG signal. The216
accelerometer was placed on the back of the subject, either at217
the center of mass or between the scapulae and its performance218
during the microgravity phases of parabolic flights was tested219
by Migeotte et al. [27]–[29].220
He et al. placed a tri-axial MEMS accelerometer for BCG221
measurement in a plastic mount over the ear, with auxiliary222
sensors include for ECG and / or photoplethysmogram (PPG)223
measurement, respectively, [30], [31]. Hyun et al. used an224
electromagnetic film (EMFi) patch to measure the vibrations225
of the chest wall in the dorso–ventral direction (transverse);226
however, it should be noted that the exact position on the227
chest for the measurement was not provided, and on the ba-228
sis of morphology, while the signal was called the BCG, it229
was likely rather an SCG [32]. Another notable approach—Q1 230
that is not exactly a wearable device, but provides some similar231
advantages—was demonstrated by Balakrishnan et al. with the232
head-to-foot (longitudinal) direction ballistocardiographic dis-233
placements of the head being captured and processed from video234
recordings [33].235
B. Weighing Scale BCG236
The first measurement of BCG on an electronic scale was237
demonstrated in 1990 by Jim Williams of Linear Technology, as238
described in his application note AN-43 [34]. Williams built an239
elegant circuit capable of measuring bodyweight with tremen-240
dous accuracy—4.5 g resolution up to 136 kg—and found mo-241
tion artifacts, and the BCG as the largest sources of noise for 242
his measurements. 243
The main advantage with weighing-scale-based BCG mea- 244
surement is that the subject is standing up for the measurement— 245
ironically, this is also the main disadvantage. While the standing 246
posture of the subject is ideal for ensuring that the measurement 247
is purely longitudinal, it also means the measurements are sus- 248
ceptible to motion artifacts and floor vibrations. This also places 249
a practical limit on the duration of the measurements, as the pa- 250
tient will likely only stand still on the scale for 30–60 s at a time at 251
most. Another key advantage of these systems is that they lever- 252
age the tremendous popularity of weighing scales, with more 253
than 80% of American households owning a scale, and multiple 254
companies developing new and improved “smart” scales with 255
enhanced capabilities. The scale is also used by heart failure pa- 256
tients at home to monitor increasing trends in their bodyweight, 257
which may be related to increased fluid retention [35], [36]. 258
With these potential advantages in mind, researchers have 259
rigorously investigated this mode of BCG measurement. Inan 260
et al. measured the mechanical frequency response of several 261
commercially available scales at various loads to determine if 262
the bandwidth was sufficient for BCG recording over a wide 263
range of bodyweight. For bodyweights up to 160 kg, they found 264
that the mechanical systems of most commercial scales have 265
a bandwidth exceeding 15 Hz, which is sufficient for BCG 266
measurement [15]. Note that for preserving the accuracy of 267
time interval detection from the BCG, such as the R–J interval 268
between the ECG and BCG, analog and digital low-pass filtering 269
operations should not use a cutoff frequency lower than 25 Hz 270
[37]. BCG measurement on a scale has also been successfully 271
demonstrated by Gonzalez-Landaeta et al. [38] and Shin et al. 272
[39], and in all studies the shape and amplitude of the signal is 273
very similar to the traditional BCG recordings taken by Starr 274
et al. nearly a century earlier [1]. 275
C. Bed-Based BCG Systems 276
BCG can be applied in evaluating the sleep stages and sleep 277
related disorders in more comfortable environment replacing 278
some functions done by polysomnography (PSG). Since BCG- 279
based technology does not require attaching electrodes on pa- 280
tient body surface, it has advantage over ECG of not disturb- 281
ing subject’s ordinary sleep behaviors in collecting data. BCG 282
measurement can be integrated with the subject’s sleeping en- 283
vironment using several types of sensors, the first of which was 284
a static charge sensitive bed by Alihanka et al. [40], and more 285
recently the following implementations: Pressure sensor in the 286
air mattress [41] or in pad [42], film-type force sensors [43] or 287
load cells in the legs of bed [44], microbend fiber optic BCG 288
sensor [45]–[47], EMFi sensors [48], piezoelectric film sensors 289
[49] or polyvinylidene fluoride (PVDF) sensors [50] in the mat- 290
tress pad, strain gauges [51], pneumatic [52], and hydraulic [53] 291
sensors. Some researchers have also proposed the use of sensor 292
arrays rather than single sensors to improve robustness [54], 293
[55]. As these sensors can usually provide the additional infor- 294
mation on respiration and body movement as well as heart beats, 295
this information can be incorporated with the BCG to generate 296
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sleep evaluating parameters more accurately, as well as other297
applications such as early warning in the general ward, or home298
monitoring, where rhythm and dynamics can be monitored over299
extended periods of time for predictive analytics.300
Sleep stages have mainly been classified into two levels slow301
wave sleep or non-slow wave sleep (SWS/non-SWS), or three302
levels (wake/REM/NREM) based on BCG. The earliest imple-303
mentation of BCG based sleep staging was by Watanabe and304
Watanabe [56]. Two stage classification between SWS and non-305
SWS was performed based on BCG with movement measured306
unobtrusively by a load cell installed bed [44]. Based on cal-307
culated heart rate variability (HRV) parameters, they achieved308
the mean agreement of 92.5% (kappa index of 0.62). Sleep effi-309
ciency was evaluated by detecting nocturnal awakening epochs310
in BCG measured using PVDF sensors on bed mattress [57],311
based on the principle that awakening during sleep is related312
with subtle changes in heart rate; thus, awakening epochs can313
be detected based on HRV parameters. They achieved the clas-314
sification accuracy of 97.4% (kappa index of 0.83) and 96.5%315
(kappa index of 0.81) and evaluated the sleep efficiency with316
absolute error of 1.08% and 1.44% for normal subjects and317
obstructive sleep apnea patients, respectively.318
Three stage classification (Wake/REM/NREM) of sleep has319
been derived using the analyses of spectral components of the320
heartbeats extracted from multichannel BCG based on EMFi321
sensors [58]. By applying a hidden Markov model only on BCG,322
they achieved a total accuracy of 79% (kappa index of 0.43)323
compared to clinical sleep staging from PSG. The performance324
was enhanced by combining the time variant-autoregressive325
model (TVAM) and wavelet discrete transform (WDT) with the326
quadratic (QD) or linear discriminant (LD) analysis [59]. The327
QD-TVAM algorithm achieved a total accuracy of 76.8% (kappa328
index of 0.55), while LD-WDT achieved a total accuracy of 79%329
(kappa index of 0.51). Although there was also a study done330
for sleep stage classification into four levels (wake/REM/deep331
sleep/light sleep) with ECG [60], four-level sleep stage clas-332
sification with BCG is not reported yet. With the ECG sig-333
nal, Tanida et al. classified the sleep stage with HRV analyzed334
for each 60-s epoch of ECG and calculated at three frequency335
band powers. Their results for minute-by minute agreement rate336
ranged from 32% to 72% with an average of 56% for ten healthy337
women.338
Sleep monitoring based on BCG technology has a potential to339
provide both continuous and longitudinal information on a sub-340
jects’ sleep quality and may take a role as a predictive screening341
method prior to the sleep studies based on PSG. It could also fill342
the gap among PSG of whole night examination and portable343
ambulatory PSG, which can be applied at home and simplified344
with, for example, a wrist worn movement sensor.345
D. Chair-Based BCG and SCG systems346
Chair-based systems have mainly used electromechanical347
film (EMFi) sensors based on piezoelectric transduction. Koivis-348
toinen et al. attached EMFi sensors to a chair to measure BCG349
signals from two seated subjects, and found the signal shape350
to be similar to other BCG measurements from the literature351
[61]. Walter et al. placed an EMFi mat in the cushion of the 352
driver’s seat in a car to measure the BCG for automatically 353
monitoring driver fitness [62]. These systems provide a means 354
for measuring BCG or SCG signals from patients who cannot 355
stand still on their own, minimize motion artifacts, and allow 356
the user to be comfortable during the measurement. The main 357
disadvantages for chair-based BCG recording are the reduction 358
of signal amplitude compared to measurements using table, bed, 359
or weighing scale systems, and the effects of postural changes 360
on signal quality. 361
IV. SIGNAL PROCESSING AND MODELING 362
A. Heartbeat Detection 363
Since heart rate is regulated by the autonomic nervous system, 364
the analysis of HRV is currently employed to obtain physiolog- 365
ical and clinical information on the level of sympathetic and 366
parasympathetic drive to the heart. Even though ECG is the 367
most widely used biological signal to evaluate heart rate dy- 368
namics, BCG may also be used. Due to its easier application for 369
monitoring in contrast to the inconvenience of attaching elec- 370
trodes to the skin in ECG measurement, BCG may facilitate the 371
assessment of heart rate dynamics in daily life [63]. 372
Heartbeats may be identified by the J-wave peak in the BCG 373
signal, i.e., the point of highest amplitude in the BCG waveform. 374
Heart rate is evaluated by measuring the interval between con- 375
secutive J-peaks, the J-J interval. As there are many algorithms 376
to detect the R-peak in ECG, there are also various methods to 377
detect the J-peaks or heart beat from BCG. Since BCG can be 378
measured in different settings with different type of sensors, the 379
peak-detection algorithm should be selected to optimize the per- 380
formance considering the characteristics of measured BCG. A 381
heartbeat detection algorithm which showed high performance 382
in R-peak detection from ECG can be applied with minor mod- 383
ification for J-peak detection. Generally the peak detection pro- 384
cedure is applied to select the highest value in amplitude as the 385
J-peak within the sliding window after some preprocessing to 386
increase signal-to-noise ratio (SNR) and to reject artifacts due 387
to motion or other interferences. 388
Choi et al. demonstrated increased detection performance 389
with a dedicated algorithm, which finds local peaks in four di- 390
vided subintervals within a period and selects the maximum 391
peak as J-peak from these local peaks with some rejection rules 392
[44]. Jansen et al. applied a detection method based on a “tem- 393
plate matching” rule by evaluating a correlation function in a 394
local moving window [64], a method which was further refined 395
and developed by Shin et al. [65]. Although this method requires 396
template design in its first stage, Shin et al. successfully applied 397
it to several types of BCG signals acquired from air mattress, 398
load cells, and EMFi sensors. The results showed 95.2% of sen- 399
sitivity and 94.8% of specificity in average for five subjects and 400
three types of BCG signals. Additional methods for heartbeat 401
detection from BCG signals include those which combine differ- 402
ent estimators [46], [66], [67], and methods which use wavelets 403
to preprocess the signal prior to peak detection [53], [68]. 404
Heart rate was estimated from the spectral domain specially 405
focusing on third harmonics especially in BCG signals acquired 406
IE
EE
Pr
oo
f
6 IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, VOL. 00, NO. 00, 2014
with fiber optic sensors [45]. The results showed an error less407
than 0.34 beat/min in 2°min averaged heart rate. Heartbeat in-408
tervals were calculated with the cepstrum method, by applying409
FFT for short time windows including pair of consequent heart410
beats [48]. Relative error of the method was 0.35% for 15 night411
recordings with six normal subjects after rejecting movement412
artifacts. Since the results of heart beat detection are not per-413
fect, generally visual editing is required to correct the errors in414
peak detection for further application like HRV analysis. Multi-415
channel fusion techniques have also been demonstrated recently416
for BCG-based heartbeat detection [48], [69].417
Recently, Paalasmaa et al. [70] and Brueser et al. [71] both418
verified heartbeat detection algorithms on large datasets contain-419
ing hundreds of thousands of heartbeats recorded in uncontrolled420
environments. Paalasmaa et al. used hierarchical clustering to421
first infer a heartbeat shape from the recordings, then beat-to-422
beat intervals were found by determining positions at which this423
template best fit the signal. The mean beat-to-beat interval error424
was 13 ms from 46 subjects in the clinic, home, single bed, dou-425
ble bed, and with two sensor types. Brueser et al. demonstrated426
robust estimation of heartbeats for 33 subjects of which 25 were427
insomniacs, with a mean beat-to-beat interval error of 0.78%.428
Their method used three short-time estimators combined using a429
Bayesian approach to continuously estimate interbeat intervals.430
Automatic template learning approaches were also presented by431
Brueser et al. in 2011 with low error [51].432
Performance of HRV analysis using BCG measured on433
weighing scale-type load cell is evaluated in reference to the434
ECG during the resting and under each condition of Valsalva435
and postexercise sessions that induce cardiac autonomic rhythm436
changes [72]. Time domain, frequency domain, and nonlinear437
domain HRV parameters were evaluated on 15 healthy subjects438
to assess the cardiac autonomic modulation under each of these439
conditions. For all subjects and for all experimental sessions,440
HRV parameters calculated from BCG peak intervals are sta-441
tistically not different from those obtained from the reference442
ECG. The results showed high performance with relative errors443
of 5.0–6.0% and strong correlation of 0.97–0.98 in average for444
these three states compared with the results from ECG peaks.445
The errors were relatively high in HRV parameters reflecting the446
high-frequency characteristics of heart rates such as HF, LF/HF447
in the spectral analysis, pNN50 in time-domain analysis, and448
SD1 in nonlinear analysis. This is considered to be caused by449
the inaccuracy in detecting peak from the less sharp J-peak of450
BCG compared to the R-peak in ECG. HRV estimates with451
BCG have also been compared to the PPG, and the correlation452
between the two was found to be high [73]. Preliminary work453
was recently presented by Brueser et al. for unsupervised HRV454
estimation from BCG signals [74].455
B. Noise and Interference Reduction456
Several sources of noise and interference can potentially cor-457
rupt BCG and SCG measurements taken using modern systems.458
These include sensor and circuit noise [75], motion artifacts459
[15], [21], [76], [77], and floor vibrations (for standing BCG460
measurements) [78].461
Both BCG and SCG represent low-level signals that con- 462
tain very low-frequency information—this can lead to problems 463
with flicker (1/f) noise in the sensor interface circuit corrupt- 464
ing the measurements. Furthermore, many diseased subjects, 465
and elderly subjects, have smaller signal amplitudes compared 466
to the healthy young population [79]. The sensor and circuit 467
noise were characterized and reduced for weighing-scale-based 468
BCG systems using an ac-bridge amplifier approach [75]. This 469
approach led to a SNR improvement of 6 dB. 470
For ambulatory and standing subjects, motion artifacts present 471
the greatest potential obstacle to achieving reliable measure- 472
ments. Unlike bed or chair systems, where the subject stays 473
generally still for the measurement, postural sway, or ambulation 474
can create unwanted peaks or distortion in the measured signals. 475
Motion artifact detection for standing BCG measurements was 476
accomplished using auxiliary sensors as noise references; then, 477
gating the BCG signal based on the detection of excessive noise 478
[76], [80]. In one study, the noise reference was an extra strain 479
gauge added to the scale to detect postural sway [76]. In another 480
study, the rms power of the electromyogram signal from the feet, 481
indicating the presence of increased muscle contractions due to 482
excessive movement, was used as a noise gate for the BCG [80]. 483
Pandia et al. presented preliminary methods for cancelling mo- 484
tion artifacts in SCG signals from walking subjects, improving 485
overall heartbeat detection [77]. Di Rienzo et al. used an au- 486
tomatic selection of movement-free data segments from daily 487
recordings of SCG signals from ambulant subjects, followed by 488
an ECG triggered ensemble averaging to reduce signal noise 489
[21]. This enabled, for the first time, the assessment of systolic 490
time interval profiles during normal daily living. 491
BCG measurements taken in a direction orthogonal to 492
the plane of the floor can potentially be corrupted by floor 493
vibrations—this can particularly pose a challenge for measure- 494
ments taken on a vehicle [62] or plane [81]. Walter et al. instru- 495
mented the seat of a car with an EMFi mat to measure the BCG, 496
aiming to use the information to monitor driver fitness [62]. 497
However, with the engine turned on, the BCG was corrupted 498
by vibration artifacts and rendered unusable. Inan et al. used 499
an auxiliary sensor for vibration detection and adaptive noise 500
cancellation to cancel floor vibration artifacts in the BCG mea- 501
surement [78]. In this study, high-quality BCG measurements 502
were successfully demonstrated from a subject standing on a 503
bus with the engine turned on and idling. Additionally, it was 504
observed that low-noise SCG waveforms could be obtained in a 505
subject sitting in the metro, while a train was going by, with the 506
above mentioned ensemble averaging approach [21]. 507
C. Signal Modeling 508
Modeling of SCG and BCG provides a tool to better un- 509
derstand the genesis of waves in these signals and to simulate 510
their morphological changes with different myocardial abnor- 511
malities. Modeling of BCG goes back to the early years of 512
ballistocardiographic research [79]. 513
In most BCG recording systems, the recording device is quite 514
small compared to the human body and the platform on which 515
it rests. It is also far away from the heart in most cases; thus, 516
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Fig. 3. Schematic showing the subject (with mass, ms ) and the BCG recording
system (with mass, mb ) coupled by a spring dashpot system.
TABLE II
DESCRIPTIONS OF VARIABLES FOR SIGNAL MODELING
Variable Description
Fi n t Internal forces
β Damping constant
y Displacement or (in subscript) indicating
head-to-foot direction
y˙ Velocity
y¨ Acceleration
D Spring constant
ms Mass of subject
mb Mass of recording device
the volume of the heart has been neglected in such models. The517
heart has been modeled like a point source providing the flow518
to the circulation system model [82]. Such a model is in accor-519
dance with the classical definition of BCG to be resulted through520
movement of center of gravity of the body and platform. On the521
contrary, in SCG the recording device (i.e., accelerometer) is522
near the heart and the volume of the heart cannot be neglected523
in any model dealing with SCG or any other precordial vibra-524
tion signal. Thus, except for some preliminary efforts [83] SCG525
modeling has not been pursued by many researchers, probably526
because of the complications associated with such a model.527
In ballistocardiographic research, one can study the events528
within human body that cause its movement in space, regard-529
less of the recording device or to study the properties of in-530
struments recording them and how their record relates to the531
movement originating them. Both of these two approaches are532
briefly introduced.533
1) Modeling the Recording Device: During the early years534
of ballistocardiographic research, several different instruments535
were used to measure BCGs, from beds hanging from the ceiling536
[84] to tables strongly coupled to ground [1]. These instruments537
were giving different records from the same normal subjects. So,538
efforts were made to model the effect of these instruments on539
BCG morphology. Limiting ourselves to the head–foot direction540
the equation giving the components along the y-axis (Fig. 3,541
variables defined in Table II) reads:542
(Fint)y − βy˙ −Dy = (ms + mb)y¨. (1)
After sorting and substituting (Fint)y into msy¨c (where y¨c is543
the acceleration of center of mass of body):544
(ms + mb)y¨ + βy˙ + Dy = ms y¨c . (2)
From the above equation, three different classic types of 545
BCGs can be conceived based on the fact that which terms on 546
the left side of the above equation can be neglected. The first is 547
(ms + mb)y¨ = ms y¨c (3)
which means that the movement of bed and body is proportional 548
to the movement of the center of gravity. A good approximation 549
of this special case is when the ballistocardiograph is weakly 550
coupled to the environment such as ultralow frequency BCG 551
(ULF-BCG) systems. 552
The second type is when: 553
y˙ =
ms
β
y¨c (4)
which represents Nickersons’s low-frequency (LF) BCG and 554
the third type is when: 555
y =
ms + mb
β
y¨c (5)
which refers to the situation when BCG is strongly coupled to 556
its environment, which were categorized under high-frequency 557
BCG (HF-BCG). In other words, when the resonance frequency 558
of the BCG platform is much higher than heart frequency, then 559
its displacement is proportional to the internal acceleration of 560
body’s center of gravity. 561
From this theoretical evaluation, it is clear that very different 562
results will be obtained when one records any one aspect of 563
motion such as displacement or acceleration from each of the 564
three ideal types of ballistocardiographs [82]. However, there is 565
a fourth category of classical BCGs, which are the direct body 566
recordings based on AHA consensus paper on BCG terminol- 567
ogy [85]. Direct body BCGs were always criticized for their 568
inconsistencies [82]. 569
2) Modeling the Internal Forces: Starr started on BCG mod- 570
eling, where arteries were segmented into 3-cm long pieces and 571
mass of blood in the aortic segment closest to the aortic valve 572
was multiplied by acceleration, derived from cardiac ejection 573
curve, to calculate force. This was repeated when the blood 574
volume shifted to the next segment [82]. 575
A more comprehensive model of human systemic arterial 576
tree with distributed properties was constructed in early 1960s 577
by Starr and Noordergraaf [82] and was improved later on by 578
Westerhof et al. [86]. This model was based on the fact that, 579
when using ULF systems, in which the body was free to move in 580
space in the head–foot axis, it was observed that the body moved 581
first footward and then headward during the cardiac cycle. This 582
was explained as a movement to counteract the displacement of 583
the blood mass, that, shortly after the onset of systole, is first 584
driven headward out of the heart to distend the great vessels, 585
and later footward, as the pulse wave spreads peripherally and 586
blood accumulates at a great distance from the heart in the more 587
peripheral vessels. 588
The model divided the arterial tree in 115 segments and cal- 589
culated the position of the body’s center of gravity in the lon- 590
gitudinal direction yc(t), as a function of time, by numerical 591
integration of the products of the excess masses of each segment 592
during the interval t, and the distance yi between the centre of 593
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each segment and the reference plane. Noordergraaf’s model594
was successful in quantitatively predicting the amplitudes of595
ULF BCG waves and in giving an explanation for the origin of596
the main peaks. The model was verified on the data acquired597
from an astronaut in MIR station [87], where by using the lon-598
gitudinal BCG recorded in space the model could be used to599
derive the aortic flow.600
V. HUMAN SUBJECTS STUDIES WITH MODERN SYSTEMS601
A. Correlation Studies With Healthy Subjects602
Originally, BCG and SCG were proposed as diagnostic tools603
for the clinic—for example, a patient would lie on a Starr BCG604
table, the recording would be printed on a strip chart, and the605
physician would read the recording to make a diagnosis regard-606
ing the patient’s cardiovascular health [1], [5]. However, the607
large intersubject variability in the signals hampered this ap-608
proach, particularly given the limited tools available at that time609
for signal analysis. On the contrary, studies have shown that the610
intrasubject variability in the signals over serial measurements611
is actually low [15]—except in the presence of changing cardio-612
vascular health. For this reason, in the past decade the BCG and613
SCG have been proposed as tools for monitoring changes in the614
same patient’s health overtime. Then, the subject is his/her own615
control, and intersubject variability is no longer an obstacle.616
To uncover the clinical relevance of BCG and SCG signal fea-617
tures, and to pave the way for future studies with clinical popula-618
tions, several researchers conducted human subjects studies with619
a healthy population using modern instrumentation and analysis620
tools. These studies were mainly designed with a noninvasive621
protocol for altering the hemodynamics and timing intervals of622
the heart—such as exercise, Valsalva maneuver, whole-body tilt623
testing, or lower body negative pressure (LBNP)—then, com-624
paring the changes in the BCG or SCG waveform to changes in625
a reference standard measurement, such as impedance cardiog-626
raphy (ICG) or Doppler ultrasound.627
For both BCG and SCG signals the amplitude (or rms power)628
components have been shown to modulate with changes in left629
ventricular function—in particular, changes in stroke volume630
(SV) or cardiac output (CO). Castiglioni et al. measured clav-631
icular SCG signals before and immediately after exercise and632
compared the percent changes in the peak-to-peak amplitude of633
the SCG to changes in CO as measured by the finometer model634
flow method, finding a strong correlation for four data points635
taken from four subjects [24]. Inan et al. further demonstrated636
that the changes in rms power resulting from exercise, mea-637
sured during 10 min of recovery time, were strongly correlated638
to changes in CO measured by Doppler ultrasound for 275 data639
points taken from nine subjects [88]. Tavakolian etal. trained a640
neural network to estimate SV from SCG parameters and tested641
this classifier on a separate testing dataset, finding an average642
correlation coefficient of 0.61, and Bland–Altman agreement643
limits (95% confidence) of +7.4mL, −7.6mL for 4900 heart-644
beats analyzed from eight participants [16]. It is important to645
note that these error bands are larger than what would be needed646
for absolute volume estimation using the SCG; however, this647
may be of interest for future research.648
Many researchers have also examined the time intervals both 649
within the signals themselves, and between BCG / SCG sig- 650
nal features and other physiological measurements (e.g., ECG 651
or PPG), to form a relationship between these timing inter- 652
vals to more well-known parameters [e.g., preejection period 653
(PEP), pulse transit time (PTT), or left ventricular ejection time 654
(LVET)]. The time interval between the ECG R-wave peak and 655
the BCG J-wave peak has been proposed as a surrogate for the 656
PEP—a measure of the IVC period of the heart and an index of 657
cardiac contractility [30], [89]. These authors used the Valsalva 658
maneuver and/or whole body tilt testing to modulate the PEP 659
by changing the autonomic balance between parasympathetic 660
and sympathetic drive, and compared the R-J interval to the 661
PEP measured using ICG. Etemadi et al. demonstrated a strong 662
correlation (R2 = 0.86) between the R-J interval and the PEP 663
for 2126 heartbeats across ten subjects performing the Valsalva 664
maneuver [89]. He et al. showed similar results for one example 665
subject with both the Valsalva maneuver and whole-body tilt 666
testing [30]. Tavakolian etal. proposed the interval between the 667
ECG Q-wave and the SCG AO-point as a surrogate for PEP, and 668
found strong correlation between this interval and PEP measure- 669
ment using ICG and Doppler ultrasound in 25 subjects [16]. 670
Researchers have also attempted to extract data from the BCG 671
relating to blood pressure (BP), leveraging the known relation- 672
ship between pulse wave velocity estimated using PTT, and 673
Pinheiro et al. suggested the use of BCG and PPG for PTT esti- 674
mation [90]. Shin et al. compared the R-J interval of the BCG, 675
modulated using the Valsalva maneuver, to beat-by-beat sys- 676
tolic BP (SBP) measurements taken using the Finapres system, 677
finding a strong correlation [39]. Nevertheless, Casanella et al. 678
found that, in case of hemodynamic changes induced by paced 679
respiration, this correlation between R-J interval and SBP was 680
dependent on the subject and was not always observed [91]. 681
Winokur et al. found, for one example subject, that the time 682
interval between the BCG and the PPG signal, both measured 683
at the ear, were correlated to PTT, and could thus be used to 684
estimate BP [31]. 685
Another important interval is the duration of systolic ejection, 686
the LVET, as it provides an indication of what percentage of the 687
cardiac cycle is being devoted to ejection compared to filling. 688
Tavakolian et al. used LBNP to simulate hemorrhage, and found 689
that LVET measurements taken using SCG were significantly 690
different at various stages of LBNP, and correlates with the 691
LBNP levels (R = 0.90) for 32 subjects [92]. Di Rienzo et al. 692
found that with exercise LVET changes measured using wear- 693
able SCG are in line with the changes reported in the literature 694
and obtained by traditional laboratory techniques [21], [93]. 695
B. Clinical Findings From Patients 696
With Cardiovascular Disease 697
Modern ballistocardiography and seismocardiography sys- 698
tems may be capable of monitoring slow, longitudinal changes 699
in cardiac function associated with a number of cardiovascu- 700
lar diseases. Timely noninvasive detection of subtle changes in 701
cardiac pathophysiology may one day enable daily drug dosage 702
adjustments, thus reducing costly and morbid rehospitalizations 703
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[94]. At this moment, the feasibility of this approach is investi-704
gated by the ongoing LAPTOP-HF study which, however, uses705
an implantable right atrial pressure sensor coupled to a mobile706
device that allows daily automatic dosage adjustment [95].707
Fortunately, the basis for the SCG’s clinical utility was begun708
in 1990 with the initial use of high sensitivity, LF accelerometers709
to measure precordial vibrations [96]. Significant features of the710
SCG waveform were identified and associated with key events711
in the cardiac cycle [17]. This allowed the accurate measurement712
of these features (e.g., ACs and MOs) using one sensor, greatly713
simplifying the calculation of CTIs.714
A large body of work exists on the utility and efficacy of715
CTIs [97], [98]. This knowledge combined with the ability to716
make accurate, repeatable quantitative measurements using the717
SCG resulted in the ability to conduct clinically relavent cross-718
sectional studies. Subsequently, clinical studies were undertaken719
to determine if the SCG could be used to identify changes in the720
SCG waveform resulting from myocardial ischemia [99].721
The SCG’s clinical utility in enhancing the diagnostic out-722
come of a graded exercise stress test was first shown in [100]. A723
large multicenter study demonstrated that when the combined724
results of the ECG and SCG were used, the predictive accuracy725
of detecting physiologically significant coronary artery disease726
was increased significantly over the results of the ECG alone [7].727
The introduction in the early 1990s of lightweight (<25g)728
accelerometers, whose working range extended below 1 Hz,729
made possible other clinical settings for the SCG. The SCG730
as a magnetic-field-compatible alternative to the electrocardio-731
gram for cardiac stress monitoring [101] was made possible732
using a newly introduced light weight piezoelectric accelerom-733
eter (336C, PCB Piezotronics, Depew, NY, USA).734
The SCG was used to measure CTI’s during atrial, ventricular,735
and biventricular pacing, as compared to normals [102]. One of736
the studies objectives was to determine the utility of the SCG737
in cardiac resynchronization therapy (CRT). This study was the738
first to use 3 SCG traces for analysis, i.e., one accelerometer739
was placed on the xyphoid process, a second over the apex at740
the fourth intercostal, and a third on the right carotid pulse.741
In 1994, the SCG was used to make accurate longitudinal742
measurements in a study of the effects of elgodiphine on cardiac743
hemodynamics [103]. In a sports medicine application, exercise744
capacity was evaluated using the SCG [104]. A more extensive745
review of the SCG is available in [105].746
As a note of interest, the combined patient population of747
the myocardial ischemia studies [7], [100] is close to 2000748
and consists of both healthy and disease subjects. All the raw749
data were recorded with the same instrumentation (SCG 2000,750
SeisMed Instruments, Minneapolis, MN, USA) associated with751
these datasets are complete patient demographics. A project752
is underway to make the raw data available on the PhysioNet753
website for study by interested researchers [105].754
More recent findings with BCG and SCG further support that755
the signals have great potential in allowing proactive cardiac756
disease management without a costly implantable device. How-757
ever, despite stated clinical and/or physiologic motivations, the758
overwhelming majority of modern BCG/SCG findings continue759
to be from healthy subjects [106]–[108]. Notable exceptions in-760
clude a bed-mounted BCG system for automated detection of 761
atrial fibrillation [109], the observation of reduced signal ampli- 762
tude in the setting of premature atrial or ventricular contractions 763
[15], and the reduction of signal consistency in heart failure 764
patients concordant with worsening clinical outcome [110]. 765
One particular subset of patients is particularly well suited for 766
study using cardiomechanical signals, those undergoing CRT. 767
CRT patients have abnormal cardiac conduction causing in a 768
significant delay between the pumping action of the various 769
chambers of the heart. CRT involves precisely adjusting the 770
timing of a multichamber pacemaker to reduce or remove these 771
delays. Such timing is difficult to ascertain using available tech- 772
nologies, spawning the field of “CRT optimization.” Researchers 773
recently demonstrated the benefits of intracardiac acceleration 774
monitoring in performing CRT optimization [111], a finding 775
preliminarily corroborated by BCG findings as well [8]. 776
C. 3-D Ballistocardiography and Microgravity Studies 777
As the sections on instrumentation earlier in this review have 778
indicated, measurements of BCG (in particular) are constrained 779
by the coupling of the body to the ground, a direct result of the 780
influence of gravity. As such, full 3-D recordings of the BCG 781
are difficult in the terrestrial environment, and much of the focus 782
has been on accelerations in the coronal plane (the XY plane as 783
defined in the section on measurement axes). 784
Given this limitation, it is therefore not surprising that the 785
idea of measuring the BCG in a subject in free-fall (weightless- 786
ness, zero-G, microgravity) was an obvious target of investiga- 787
tion. The first such experiment was performed in the 1960s in 788
parabolic flight, with the subject strapped into a “tub,” which 789
was itself instrumented to record the BCG [9]. Despite the lim- 790
ited periods of microgravity available (typically 20 s) and the 791
subject restraints, recordings of good quality were obtained. 792
Spaceflight represents the other obvious environment in 793
which the “true” 3-D BCG can be recorded. The earliest record- 794
ings were made by the Soviets on Saluyt-6 [10] and consisted of 795
a series of five recordings were performed in two crew members 796
of a long duration mission on days 46, 71, 98, 133, and 175. 797
A piezoelectric sensor, attached close to the center of mass, 798
recorded ballistic forces in the feet-to-head axis during breath 799
holding experiments. Individual changes were seen during the 800
mission with maximum amplitude of the IJ wave occurring on 801
day 133. Measurements were also made during the Spacelab-1 802
mission aboard the Space Shuttle in 1983 [112]. These exper- 803
iments were conducted in two subjects at two occasions dur- 804
ing this short duration spaceflight and showed an increase of 805
the overall systolic accelerations along the longitudinal axis in 806
microgravity. 807
Perhaps the best-analyzed dataset of the BCG in spaceflight 808
came from measurements made during the Spacelab D-2 mis- 809
sion in 1993. During that flight, extra time became available (due 810
to an extension of the overall mission length), and an experiment 811
was hastily conceived, approved, implemented, and performed 812
to measure 3-D BCG in a free-floating subject. Parenthetically, 813
this may be one of the fastest spaceflight experiments ever de- 814
veloped with the time from concept, to collection of the data 815
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Fig. 4. Subject in D-2 shown wearing the snuggly-fitting suit incorporating a
respiratory inductance plethysmograph and ECG. Photo Credit: NASA.
(including approval of an institutional review board) was only816
4–5 days, surely some sort of record. The experiment utilized817
data from a free-floating subject instrumented with an ECG818
and wearing a snuggly fitting suit that measured respiratory819
motion using an impedance plethysmograph (see Fig. 4). This820
instrumentation was a part of the Anthrorack series of human821
studies managed by the European Space Agency. The second822
cruicial piece of instrumentation was a set of high-fidelity tri-823
axial accelerometer that were attached to the vehicle and used824
for measuring the accelerations imparted by crew activity in825
the Spacelab. The sensor package was detached from the ve-826
hicle and taped to the lumbar region of the subject, near to827
the (presumed) center of mass. Data were then recorded as828
the subject remained stationary and free floated in the center829
of the Spacelab, providing a continuous recording, free of in-830
terruptions of 146 s. In order to synchronize the two separate831
data streams, collisions with the Spacelab structure, which dis-832
rupted signals in both data streams, were used as posthoc event833
source [11].834
The data from the D-2 study and some subsequent studies835
provided valuable insight into several aspects of the BCG. In836
particular there were four major conclusions derived from this837
dataset.838
1) Lung volume greatly influences the accelerations839
recorded, especially in the longitudinal (head-to-foot)840
body axis (see Fig. 5), with the implication being that841
there is better coupling between the heart and the body in842
the longitudinal axis at higher lung volumes [11]. Inter-843
estingly, the actual direction of respiratory motion (mid844
inspiration versus mid expiration) had only minimal in-845
fluence of the BCG.846
2) Data derived from short periods of microgravity in847
parabolic flight are largely equivalent to data obtained848
in sustained microgravity [113].849
3) The BCG has a plane of symmetry that is primarily sagit-850
tal. This suggests that 2-D recordings performed in a851
supine subject (i.e., coronal recordings) fail to capture852
a significant portion of the effect of the blood ejection on853
the body, complicating their interpretation [113].854
Fig. 5. The 3-D BCG recorded in spaceflight in a free-floating subject, at the
end of a normal expiration (dashed lines, functional residual capacity, FRC), and
at the end of a normal inspiration (solid lines, FRC + tidal volume). From [11].
4) The accelerations that are recording in a 2-D system are 855
only modestly correlated with the true 3-D accelerations 856
that actually occur, again complicating their interpretation 857
[113]. 858
BCG flight experiments were also an integral part of the 859
Russian cardiovascular research program for the orbital sta- 860
tion MIR. BCG along the head-to-foot direction was measured 861
in three crew members during the second MIR mission in 862
1988 and compared to SCG recordings. Significant changes 863
of the BCG amplitudes (HI, IJ, JK) during the long-term flight 864
were described together with large inter individual differences. 865
The first true 3-D-BCG recordings were made during the sixth 866
MIR mission in 1990 in two crew members on flight days 56 867
and 110. Three new piezoelectric sensors were used placed 868
in perpendicular planes in a small cylindrical box with a di- 869
ameter of 40 mm and a height of 20 mm. The sensitivity of 870
the sensor was 20 mV/m/s2. The sensor was placed between 871
the scapulae using rubber belts and a metallic plate. The spe- 872
cial amplifier (BCG-3) was connected to the recording unit 873
“Gamma-1,” and the data were transmitted telemetrically to 874
the ground station. In summary, no dramatic changes in the vec- 875
tor sum were detected. Maximum forces ranged from 5.85 to 876
10.18 N. However, profound individual changes of the shape, 877
amplitude, and timing of the BCG, especially in the lateral 878
and dorso–ventral plane have been found. Finally, combined 879
BCG and SCG measurements have been made every month 880
in space during the 14 months space flight of Valeri Poljakov, 881
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15th to 17th MIR missions (Russian–Austrian flight experiment882
“Pulstrans”) [114].883
VI. STANDARDS AND OPEN ISSUES884
A. Need For a Standardization885
From the analysis of the literature, it appears that important886
methodological aspects concerning BCG and SCG analysis are887
still characterized by a certain level of ambiguity. These include888
1) Definitions of BCG and SCG Signals: In the literature, the889
definition of BCG and SCG is not univocal and the “BCG” term890
is even sometimes used for SCG signals.891
2) Nomenclature: Since BCG and SCG waveforms are892
mostly different (although they might have some common fea-893
tures to be investigated) it is reasonable to use a specific nomen-894
clature for defining peaks and valleys of each signal. The preva-895
lent annotation for BCG was proposed by Starr et al. [1], for896
SCG by Crow et al. [17]. However, there are some disagree-897
ments on these annotations, and in some instances, SCG peaks898
are termed with the BCG annotation.899
3) Indication of Site of Measurement, Characteristics of sen-900
sor, Sensor Axis Orientation: These pieces of information are901
crucial for data comparison and interpretation, but unfortunately902
are not invariably reported in scientific communications.903
A standardization or at least a common position on the above904
issues would greatly facilitate the understanding and comparison905
of published results, the exchange of data, and the design of new906
experimental protocols in this area.907
B. Open Issues908
A number of open issues remain to be addressed in this field to909
improve the understanding and applicability of BCG and SCG910
signals. Hereafter, we provide just a short list of these issues.911
1) The biological meaning of BCG and SCG deflections not912
yet annotated and their clinical relevance.913
2) Possible common features of the BCG and SCG signals.914
3) Further parameters derivable from the analysis of the BCG915
and SCG 3-D vectors.916
4) Effects of respiration, posture, right ventricle, and sensor917
adherence on the signal waveform/quality.918
5) How to facilitate the use of these signals in clinical prac-919
tice?920
6) Reference values for healthy and diseased subjects for921
both types of signals, and for a wide range of body922
types/sizes, and ages.923
VII. CONCLUSION AND AREAS FOR FUTURE INVESTIGATION924
The recent advances in the BCG and SCG field indicate the925
strong potential of these measurements to address wide vari-926
ety of clinical needs, in particular monitoring or trending the927
cardiomechanical health of patients outside of the clinic. Both928
BCG and SCG measurements can be taken using inexpensive929
and unobtrusive sensors, making them ideally suited, for exam-930
ple, for home monitoring of chronic diseases. Nevertheless, to931
maximize our ability to interpret these signals, the physiological932
origins of both signals must be studied further and elucidated. 933
Furthermore, there is a need to be able to map each measure- 934
ment modality to another using cardiovascular and mechanical 935
modeling of the body, such that any BCG or SCG waveform 936
amplitude, timing, or morphology measured using one modal- 937
ity can be translated quantitatively to another. For example, 938
if a bed-based recording in the dorso–ventral axis yielded a 939
peak BCG J-wave amplitude of 2 N, system modeling tools are 940
needed to compare this to a corresponding J-wave amplitude 941
measured using a weighing scale. Finally, an extensive, open 942
database of BCG and SCG signals, processing tools, and even 943
microprocessor code needs to be made available to massively 944
expand the capability of researchers around the world to inves- 945
tigate these signals, use them in their own settings, and grow the 946
field from a niche into an established technique, routinely used 947
in clinical practice. 948
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Abstract—In the past decade, there has been a resurgence in6
the field of unobtrusive cardiomechanical assessment, through7
advancing methods for measuring and interpreting ballistocardio-8
gram (BCG) and seismocardiogram (SCG) signals. Novel instru-9
mentation solutions have enabled BCG and SCG measurement10
outside of clinical settings, in the home, in the field, and even in11
microgravity. Customized signal processing algorithms have led to12
reduced measurement noise, clinically relevant feature extraction,13
and signal modeling. Finally, human subjects physiology studies14
have been conducted using these novel instruments and signal pro-15
cessing tools with promising clinically relevant results. This paper16
reviews the recent advances in these areas of modern BCG and17
SCG research.18
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I. INTRODUCTION 22
A S detailed in the following sections, the ballistocardio- 23gram (BCG) is a measurement of the recoil forces of the 24
body in reaction to cardiac ejection of blood into the vascula- 25
ture [1], while the seismocardiogram (SCG) represents the local 26
vibrations of the chest wall in response to the heartbeat [2]. 27
The BCG phenomenon was first observed in 1877 by Gordon, 28
with the finding that, as a subject would stand on a weighing 29
scale, the needle would vibrate synchronously to the subject’s 30
heartbeat [3]. Nearly 60 years later, Starr and colleagues created 31
an instrument in the form of a table with a mobile top surface 32
to measure the BCG in a repeatable scientific manner [1]. The 33
SCG was first observed by Bozhenko in 1961, and was first 34
applied in clinical studies 30 years later in 1991 by Salerno and 35
Zanetti [4]. Throughout the 1900s, both BCG and SCG signals 36
were heavily investigated and several publications appeared in 37
major scientific and clinical journals (e.g., [4]–[7]). However, 38
because of the advent of echocardiography and magnetic res- 39
onance imaging, and overly-cumbersome hardware, BCG and 40
SCG were largely abandoned by the medical community [8]. 41
Today, technological advancements largely simplify the mea- 42
surement and assessment of these signals and open new perspec- 43
tives in their clinical use. This paper reviews the instrumentation 44
and signal processing advances which have helped to propel 45
BCG and SCG into this revival. It also summarizes some of the 46
key human subjects studies performed recently that support the 47
use of BCG and SCG in extra-clinical applications. 48
II. DESCRIPTION OF BCG AND SCG SIGNALS 49
A. BCG Signal Description 50
At every heartbeat, the blood travelling along the vascular tree 51
produces changes in the body center of mass. Body micromove- 52
ments are then produced by the recoil forces to maintain the 53
overall momentum. The BCG is the recording of these move- 54
ments, can be measured as a displacement, velocity, or accelera- 55
tion signal, and is known to include movements in all three axes. 56
The longitudinal BCG is a measure of the head-to-foot deflec- 57
tions of the body, while the transverse BCG represents antero– 58
posterior (or dorso–ventral) vibrations. The original bed- and 59
table-based BCG systems focused on longitudinal BCG mea- 60
surements, representing what was supposed to be the largest 61
projection of the 3-D forces resulting from cardiac ejection 62
[1]. Table I summarizes modern BCG measurement systems 63
and their axes of measurement. Note that for some systems, 64
head-to-foot and dorso–ventral forces are unavoidably, mixed 65
2168-2194 © 2014 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
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TABLE I
MODERN BCG SYSTEMS AND THEIR CORRESPONDING MEASUREMENT AXES
Modern BCG System Axis Comments / Challenges
Accel. (0g) All (3-D) - Needs reduced gravity
Accel. (1g) Head-to-foot - Placement affects signal shape
and amplitude
- Motion artifacts must be
detected and mitigated
Bed Head-to-foot or
Dorso-ventral
- Cross-axis coupling
- Changes in sleep position affect
signal quality / shape
Chair Head-to-foot or
Dorso-ventral
- Posture affects signal quality
and repeatability
Weighing Scale Head-to-foot - Posture affects signal quality
and repeatability
- Motion artifacts must be
detected and mitigated
together in the measurement, and this should be accounted for66
when interpreting results. However, in spite of the 3-D nature of67
the BCG, for a long period of time only the microdisplacements68
of the body along the longitudinal axis (head-to-foot) were con-69
sidered. Currently, BCG is mainly measured using a force plate70
or force sensor placed on a weighing scale or under the seat of a71
chair, with the subject in a vertical position. Modern approaches72
to BCG measurement are discussed below in Section III.73
It should be considered, however, that the gravity force and74
any contact of the body with external objects, including the75
floor and measuring devices, somewhat interferes with, or even76
impedes, the body displacement induced by the recoil forces.77
As a result, the BCG measurement on earth is always affected78
by some distortion. The ideal environment for assessing the79
BCG would be in microgravity settings, such as during space80
missions. Such experiments have been performed, and the re-81
sults described below confirm that in microgravity the whole82
body recoil forces (BCG) are significant in all three dimensions83
[9]–[12]. Modeling studies examining the cardiogenic traction84
forces of the aorta have confirmed this finding as well [13].85
B. SCG Signal Description86
SCG is the measure of the thoracic vibrations produced by the87
heart’s contraction and the ejection of blood from the ventricles88
into the vascular tree. Today, the SCG can readily be detected89
by placing a low-noise accelerometer on the chest. If a tri-axial90
accelerometer is used, SCG components are present in all three91
axes, each displaying a specific pattern [12], [14]. However, in92
the literature, the majority of studies on SCG only focus on the93
amplitude of the dorso–ventral component, although it is likely94
that additional biological information could be derived also from95
the analysis of the longitudinal and lateral SCG components, and96
from the analysis of the acceleration vector trajectory during97
the heart cycle. Unless the contrary is stated to be consistent98
with the prevalent literature only the dorso–ventral acceleration99
component of SCG will be considered in the remainder of this100
paper.101
C. BCG and SCG Waveforms102
For each heart contraction, a BCG and SCG waveform is gen-103
erated. Each waveform is characterized by several peaks and val-104
Fig. 1. Simultaneously acquired Lead II electrocardiogram (ECG); three-axis
seismocardiogram (SCG) with z indicating the dorso-ventral axis, x indicating
the right-to-left lateral axis, and y indicating the head-to-foot axis; ballisto-
cardiogram (BCG); impedance cardiogram (ICG); and arterial blood pressure
(ABP) measured at the finger, signals from one subject, illustrating the relative
timing and amplitude features of the signals.
leys reflecting specific events of the beating heart. Fig. 1 shows a 105
typical ECG, head-to-foot BCG, tri-axial SCG, impedance car- 106
diogram (ICG), and arterial blood pressure (ABP) measurement 107
from a healthy subject (data were collected with approval from 108
the Institutional Review Board, IRB, at the Georgia Institute 109
of Technology, and with written informed consent obtained). A 110
high-resolution, miniature accelerometer was used for the SCG 111
data collection (356A32, PCB Piezotronics, Depew, NY, USA), 112
and a modified weighing scale was used for the BCG recording 113
as described previously in [15]. The ECG and ICG waveforms 114
were measured using the BN-RSPEC and BN-NICO wireless 115
units (BIOPAC Systems, Inc., Goleta, CA, USA) interfaced to 116
the MP150WSW data acquisition hardware (BIOPAC Systems, 117
Inc., Goleta, CA, USA). The ABP was measured from the fin- 118
ger using the A2SYS Nexfin Monitor (Edwards Lifesciences, 119
Irvine, CA, USA). For this measurement, z corresponded to the 120
dorso–ventral, y to the head-to-foot, and x to the right-to-left 121
lateral components of the SCG. The labels of the peaks and val- 122
leys of the dorso–ventral components shown in this figure are 123
according to [16], [17]; for the BCG, the labels are according 124
to [1]. For the SCG, the labels correspond to the physiological 125
event they are believed to represent: MC, mitral valve closure; 126
IVC, isovolumetric contraction; AO, aortic valve opening; RE, 127
rapid ejection; AC, aortic valve closure; MO, mitral valve open- 128
ing; and RF, rapid filling. For the BCG, the labels of the waves 129
are not associated directly with underlying events, but rather 130
the current understanding is that the waveform represents the 131
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Fig. 2. Compilation of modern BCG and SCG acquisition hardware. (a) PVDF sensor installed into the bed for BCG measurements during sleep. (b) Tri-axial
SCG measurement system built into the MagIC-SCG vest for continuous recordings during normal activities of daily living. Modified from [14] with permission.
(c) Wearable 3-D BCG measurement hardware (Pneumocard) being used on board a parabolic flight for microgravity BCG measurements; Photo Credit: ESA.
(d) Weighing scale with built in circuitry for BCG measurement from a standing subject. (e) Flexible hardware for chest-mounted tri-axial SCG measurements.
combined mechanical pulse response of the vasculature and132
body to cardiac ejection of blood [18]. Note that, when the133
BCG is measured by a scale or force plate, the SCG and BCG134
units are not the same; the SCG records the accelerations of135
the chest wall, and is thus presented in units of milligram; the136
BCG represents the displacements of the center of mass of137
the subject on the weighing scale, which are then converted138
to units of force by the spring constant for the scale platform,139
and thus it is presented in units of Newtons. The mass that is140
accelerated for the SCG is not the same as the mass acceler-141
ated for the BCG; as such, the direct conversion of the BCG to142
acceleration units or the SCG to force units has not yet been143
elucidated.144
D. Importance of Sensor Location, Axis Selection145
and Orientation146
For both BCG and SCG, the measurement location has a sig-147
nificant bearing on the morphology, amplitude, and clinically148
relevant features of the signal. For the SCG, since it is a mea-149
sure of local vibrations, the precise location of the sensor on150
the chest impacts the measured signal [19]–[21]. A widely used151
placement has been on the sternum [14], [22], [23]. Pandia et al.152
found that the second heart sound was more pronounced when153
the SCG was measured on the left side of the chest compared154
to the sternum [19]. For BCG signals measured using an ac-155
celerometer, the same is true; an accelerometer placed on the156
foot will not measure the same BCG signal as one placed on157
the head, thus stressing the importance of a clear description of,158
and thoughtfulness regarding, the sensor location on the body.159
An additional crucial issue is the orientation of the acceleration 160
axis. BCG or SCG accelerations in the dorso–ventral direction 161
will not be identical to those in the lateral (right-to-left) or head- 162
to-foot direction; consequently, depending on the purpose of 163
the measurement the axis should be chosen accordingly or a 164
three-axis accelerometer should be used. 165
In spite of the major role played by the selection of the mea- 166
surement axes, the axes orientation, and the sensor location, 167
from the review of the existing literature it appears that infor- 168
mation on these aspects is often missing, making difficult the 169
understanding of the experimental setup and the interpretation 170
of results. Thus, as detailed in Section VI, a standardization 171
on these issues is deemed necessary, and in the meantime, it 172
is advisable that the above pieces of information are clearly 173
stated in any scientific communication dealing with BCG and 174
SCG. 175
III. INSTRUMENTATION: ENABLING UBIQUITOUS MONITORING 176
Fig. 2 shows a compilation of photos depicting several exam- 177
ples of modern BCG and SCG acquisition hardware, enabling 178
data acquisition in a variety of settings, including in bed, in 179
the home, outdoors, and in microgravity. These systems are 180
discussed below in detail. 181
A. Wearable BCG or SCG Systems 182
The primary advantage of wearable BCG or SCG mea- 183
surement systems is the possibility of obtaining data contin- 184
uously throughout normal daily living. Additionally, record- 185
ings with wearable systems can potentially be acquired in any 186
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environment; thus, providing an opportunity to assess a per-187
son’s cardiovascular performance under various environmental188
settings or stressors.189
The sensor type used most often for wearable BCG or SCG190
measurements is an accelerometer, typically with three-axis191
measurement capability, that is mechanically coupled to the192
body with either adhesives, plastic mounting, or textiles. In193
2007, Castiglioni et al. tested the SCG assessment by an ex-194
ternal three-axis MEMS accelerometer placed on the left clavi-195
cle, connected to a smart garment with textile ECG electrodes,196
thus obtaining simultaneous tri-axial SCG and single-lead ECG197
recordings [24]. The concept was subsequently refined, and in198
2010, Di Rienzo et al. proposed an integrated vest equipped with199
sensors, the MagIC-SCG device, in which the accelerometer200
was inside the system electronics and placed in contact with the201
subject’s sternum [14]. Through this system, SCG was recorded202
over 24 h in ambulant subjects, while performing a variety of203
activities of normal daily living and beat-to-beat estimates of204
cardiac time intervals (CTIs) could be estimated [21]. Chuo205
et al. developed miniaturized hardware (55× 15× 3 mm) on206
a flexible substrate with adhesive backing for wireless tri-axial207
SCG recording from the sternum (also with a MEMS accelerom-208
eter) together with single-lead ECG and coarse single-point skin209
temperature via a thermistor [25]. Baevsky et al. developed a210
portable system, “Pneumocard,” for the assessment of the car-211
diac function of cosmonauts on board the International Space212
Station [26]. The system comprised a single-axis MEMS ac-213
celerometer placed at the apex of the heart for the recording of214
the SCG signal. Later, a three-axis MEMS accelerometer was215
added to the system for the recording of the BCG signal. The216
accelerometer was placed on the back of the subject, either at217
the center of mass or between the scapulae and its performance218
during the microgravity phases of parabolic flights was tested219
by Migeotte et al. [27]–[29].220
He et al. placed a tri-axial MEMS accelerometer for BCG221
measurement in a plastic mount over the ear, with auxiliary222
sensors include for ECG and / or photoplethysmogram (PPG)223
measurement, respectively, [30], [31]. Hyun et al. used an224
electromagnetic film (EMFi) patch to measure the vibrations225
of the chest wall in the dorso–ventral direction (transverse);226
however, it should be noted that the exact position on the227
chest for the measurement was not provided, and on the ba-228
sis of morphology, while the signal was called the BCG, it229
was likely rather an SCG [32]. Another notable approach—Q1 230
that is not exactly a wearable device, but provides some similar231
advantages—was demonstrated by Balakrishnan et al. with the232
head-to-foot (longitudinal) direction ballistocardiographic dis-233
placements of the head being captured and processed from video234
recordings [33].235
B. Weighing Scale BCG236
The first measurement of BCG on an electronic scale was237
demonstrated in 1990 by Jim Williams of Linear Technology, as238
described in his application note AN-43 [34]. Williams built an239
elegant circuit capable of measuring bodyweight with tremen-240
dous accuracy—4.5 g resolution up to 136 kg—and found mo-241
tion artifacts, and the BCG as the largest sources of noise for 242
his measurements. 243
The main advantage with weighing-scale-based BCG mea- 244
surement is that the subject is standing up for the measurement— 245
ironically, this is also the main disadvantage. While the standing 246
posture of the subject is ideal for ensuring that the measurement 247
is purely longitudinal, it also means the measurements are sus- 248
ceptible to motion artifacts and floor vibrations. This also places 249
a practical limit on the duration of the measurements, as the pa- 250
tient will likely only stand still on the scale for 30–60 s at a time at 251
most. Another key advantage of these systems is that they lever- 252
age the tremendous popularity of weighing scales, with more 253
than 80% of American households owning a scale, and multiple 254
companies developing new and improved “smart” scales with 255
enhanced capabilities. The scale is also used by heart failure pa- 256
tients at home to monitor increasing trends in their bodyweight, 257
which may be related to increased fluid retention [35], [36]. 258
With these potential advantages in mind, researchers have 259
rigorously investigated this mode of BCG measurement. Inan 260
et al. measured the mechanical frequency response of several 261
commercially available scales at various loads to determine if 262
the bandwidth was sufficient for BCG recording over a wide 263
range of bodyweight. For bodyweights up to 160 kg, they found 264
that the mechanical systems of most commercial scales have 265
a bandwidth exceeding 15 Hz, which is sufficient for BCG 266
measurement [15]. Note that for preserving the accuracy of 267
time interval detection from the BCG, such as the R–J interval 268
between the ECG and BCG, analog and digital low-pass filtering 269
operations should not use a cutoff frequency lower than 25 Hz 270
[37]. BCG measurement on a scale has also been successfully 271
demonstrated by Gonzalez-Landaeta et al. [38] and Shin et al. 272
[39], and in all studies the shape and amplitude of the signal is 273
very similar to the traditional BCG recordings taken by Starr 274
et al. nearly a century earlier [1]. 275
C. Bed-Based BCG Systems 276
BCG can be applied in evaluating the sleep stages and sleep 277
related disorders in more comfortable environment replacing 278
some functions done by polysomnography (PSG). Since BCG- 279
based technology does not require attaching electrodes on pa- 280
tient body surface, it has advantage over ECG of not disturb- 281
ing subject’s ordinary sleep behaviors in collecting data. BCG 282
measurement can be integrated with the subject’s sleeping en- 283
vironment using several types of sensors, the first of which was 284
a static charge sensitive bed by Alihanka et al. [40], and more 285
recently the following implementations: Pressure sensor in the 286
air mattress [41] or in pad [42], film-type force sensors [43] or 287
load cells in the legs of bed [44], microbend fiber optic BCG 288
sensor [45]–[47], EMFi sensors [48], piezoelectric film sensors 289
[49] or polyvinylidene fluoride (PVDF) sensors [50] in the mat- 290
tress pad, strain gauges [51], pneumatic [52], and hydraulic [53] 291
sensors. Some researchers have also proposed the use of sensor 292
arrays rather than single sensors to improve robustness [54], 293
[55]. As these sensors can usually provide the additional infor- 294
mation on respiration and body movement as well as heart beats, 295
this information can be incorporated with the BCG to generate 296
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sleep evaluating parameters more accurately, as well as other297
applications such as early warning in the general ward, or home298
monitoring, where rhythm and dynamics can be monitored over299
extended periods of time for predictive analytics.300
Sleep stages have mainly been classified into two levels slow301
wave sleep or non-slow wave sleep (SWS/non-SWS), or three302
levels (wake/REM/NREM) based on BCG. The earliest imple-303
mentation of BCG based sleep staging was by Watanabe and304
Watanabe [56]. Two stage classification between SWS and non-305
SWS was performed based on BCG with movement measured306
unobtrusively by a load cell installed bed [44]. Based on cal-307
culated heart rate variability (HRV) parameters, they achieved308
the mean agreement of 92.5% (kappa index of 0.62). Sleep effi-309
ciency was evaluated by detecting nocturnal awakening epochs310
in BCG measured using PVDF sensors on bed mattress [57],311
based on the principle that awakening during sleep is related312
with subtle changes in heart rate; thus, awakening epochs can313
be detected based on HRV parameters. They achieved the clas-314
sification accuracy of 97.4% (kappa index of 0.83) and 96.5%315
(kappa index of 0.81) and evaluated the sleep efficiency with316
absolute error of 1.08% and 1.44% for normal subjects and317
obstructive sleep apnea patients, respectively.318
Three stage classification (Wake/REM/NREM) of sleep has319
been derived using the analyses of spectral components of the320
heartbeats extracted from multichannel BCG based on EMFi321
sensors [58]. By applying a hidden Markov model only on BCG,322
they achieved a total accuracy of 79% (kappa index of 0.43)323
compared to clinical sleep staging from PSG. The performance324
was enhanced by combining the time variant-autoregressive325
model (TVAM) and wavelet discrete transform (WDT) with the326
quadratic (QD) or linear discriminant (LD) analysis [59]. The327
QD-TVAM algorithm achieved a total accuracy of 76.8% (kappa328
index of 0.55), while LD-WDT achieved a total accuracy of 79%329
(kappa index of 0.51). Although there was also a study done330
for sleep stage classification into four levels (wake/REM/deep331
sleep/light sleep) with ECG [60], four-level sleep stage clas-332
sification with BCG is not reported yet. With the ECG sig-333
nal, Tanida et al. classified the sleep stage with HRV analyzed334
for each 60-s epoch of ECG and calculated at three frequency335
band powers. Their results for minute-by minute agreement rate336
ranged from 32% to 72% with an average of 56% for ten healthy337
women.338
Sleep monitoring based on BCG technology has a potential to339
provide both continuous and longitudinal information on a sub-340
jects’ sleep quality and may take a role as a predictive screening341
method prior to the sleep studies based on PSG. It could also fill342
the gap among PSG of whole night examination and portable343
ambulatory PSG, which can be applied at home and simplified344
with, for example, a wrist worn movement sensor.345
D. Chair-Based BCG and SCG systems346
Chair-based systems have mainly used electromechanical347
film (EMFi) sensors based on piezoelectric transduction. Koivis-348
toinen et al. attached EMFi sensors to a chair to measure BCG349
signals from two seated subjects, and found the signal shape350
to be similar to other BCG measurements from the literature351
[61]. Walter et al. placed an EMFi mat in the cushion of the 352
driver’s seat in a car to measure the BCG for automatically 353
monitoring driver fitness [62]. These systems provide a means 354
for measuring BCG or SCG signals from patients who cannot 355
stand still on their own, minimize motion artifacts, and allow 356
the user to be comfortable during the measurement. The main 357
disadvantages for chair-based BCG recording are the reduction 358
of signal amplitude compared to measurements using table, bed, 359
or weighing scale systems, and the effects of postural changes 360
on signal quality. 361
IV. SIGNAL PROCESSING AND MODELING 362
A. Heartbeat Detection 363
Since heart rate is regulated by the autonomic nervous system, 364
the analysis of HRV is currently employed to obtain physiolog- 365
ical and clinical information on the level of sympathetic and 366
parasympathetic drive to the heart. Even though ECG is the 367
most widely used biological signal to evaluate heart rate dy- 368
namics, BCG may also be used. Due to its easier application for 369
monitoring in contrast to the inconvenience of attaching elec- 370
trodes to the skin in ECG measurement, BCG may facilitate the 371
assessment of heart rate dynamics in daily life [63]. 372
Heartbeats may be identified by the J-wave peak in the BCG 373
signal, i.e., the point of highest amplitude in the BCG waveform. 374
Heart rate is evaluated by measuring the interval between con- 375
secutive J-peaks, the J-J interval. As there are many algorithms 376
to detect the R-peak in ECG, there are also various methods to 377
detect the J-peaks or heart beat from BCG. Since BCG can be 378
measured in different settings with different type of sensors, the 379
peak-detection algorithm should be selected to optimize the per- 380
formance considering the characteristics of measured BCG. A 381
heartbeat detection algorithm which showed high performance 382
in R-peak detection from ECG can be applied with minor mod- 383
ification for J-peak detection. Generally the peak detection pro- 384
cedure is applied to select the highest value in amplitude as the 385
J-peak within the sliding window after some preprocessing to 386
increase signal-to-noise ratio (SNR) and to reject artifacts due 387
to motion or other interferences. 388
Choi et al. demonstrated increased detection performance 389
with a dedicated algorithm, which finds local peaks in four di- 390
vided subintervals within a period and selects the maximum 391
peak as J-peak from these local peaks with some rejection rules 392
[44]. Jansen et al. applied a detection method based on a “tem- 393
plate matching” rule by evaluating a correlation function in a 394
local moving window [64], a method which was further refined 395
and developed by Shin et al. [65]. Although this method requires 396
template design in its first stage, Shin et al. successfully applied 397
it to several types of BCG signals acquired from air mattress, 398
load cells, and EMFi sensors. The results showed 95.2% of sen- 399
sitivity and 94.8% of specificity in average for five subjects and 400
three types of BCG signals. Additional methods for heartbeat 401
detection from BCG signals include those which combine differ- 402
ent estimators [46], [66], [67], and methods which use wavelets 403
to preprocess the signal prior to peak detection [53], [68]. 404
Heart rate was estimated from the spectral domain specially 405
focusing on third harmonics especially in BCG signals acquired 406
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with fiber optic sensors [45]. The results showed an error less407
than 0.34 beat/min in 2°min averaged heart rate. Heartbeat in-408
tervals were calculated with the cepstrum method, by applying409
FFT for short time windows including pair of consequent heart410
beats [48]. Relative error of the method was 0.35% for 15 night411
recordings with six normal subjects after rejecting movement412
artifacts. Since the results of heart beat detection are not per-413
fect, generally visual editing is required to correct the errors in414
peak detection for further application like HRV analysis. Multi-415
channel fusion techniques have also been demonstrated recently416
for BCG-based heartbeat detection [48], [69].417
Recently, Paalasmaa et al. [70] and Brueser et al. [71] both418
verified heartbeat detection algorithms on large datasets contain-419
ing hundreds of thousands of heartbeats recorded in uncontrolled420
environments. Paalasmaa et al. used hierarchical clustering to421
first infer a heartbeat shape from the recordings, then beat-to-422
beat intervals were found by determining positions at which this423
template best fit the signal. The mean beat-to-beat interval error424
was 13 ms from 46 subjects in the clinic, home, single bed, dou-425
ble bed, and with two sensor types. Brueser et al. demonstrated426
robust estimation of heartbeats for 33 subjects of which 25 were427
insomniacs, with a mean beat-to-beat interval error of 0.78%.428
Their method used three short-time estimators combined using a429
Bayesian approach to continuously estimate interbeat intervals.430
Automatic template learning approaches were also presented by431
Brueser et al. in 2011 with low error [51].432
Performance of HRV analysis using BCG measured on433
weighing scale-type load cell is evaluated in reference to the434
ECG during the resting and under each condition of Valsalva435
and postexercise sessions that induce cardiac autonomic rhythm436
changes [72]. Time domain, frequency domain, and nonlinear437
domain HRV parameters were evaluated on 15 healthy subjects438
to assess the cardiac autonomic modulation under each of these439
conditions. For all subjects and for all experimental sessions,440
HRV parameters calculated from BCG peak intervals are sta-441
tistically not different from those obtained from the reference442
ECG. The results showed high performance with relative errors443
of 5.0–6.0% and strong correlation of 0.97–0.98 in average for444
these three states compared with the results from ECG peaks.445
The errors were relatively high in HRV parameters reflecting the446
high-frequency characteristics of heart rates such as HF, LF/HF447
in the spectral analysis, pNN50 in time-domain analysis, and448
SD1 in nonlinear analysis. This is considered to be caused by449
the inaccuracy in detecting peak from the less sharp J-peak of450
BCG compared to the R-peak in ECG. HRV estimates with451
BCG have also been compared to the PPG, and the correlation452
between the two was found to be high [73]. Preliminary work453
was recently presented by Brueser et al. for unsupervised HRV454
estimation from BCG signals [74].455
B. Noise and Interference Reduction456
Several sources of noise and interference can potentially cor-457
rupt BCG and SCG measurements taken using modern systems.458
These include sensor and circuit noise [75], motion artifacts459
[15], [21], [76], [77], and floor vibrations (for standing BCG460
measurements) [78].461
Both BCG and SCG represent low-level signals that con- 462
tain very low-frequency information—this can lead to problems 463
with flicker (1/f) noise in the sensor interface circuit corrupt- 464
ing the measurements. Furthermore, many diseased subjects, 465
and elderly subjects, have smaller signal amplitudes compared 466
to the healthy young population [79]. The sensor and circuit 467
noise were characterized and reduced for weighing-scale-based 468
BCG systems using an ac-bridge amplifier approach [75]. This 469
approach led to a SNR improvement of 6 dB. 470
For ambulatory and standing subjects, motion artifacts present 471
the greatest potential obstacle to achieving reliable measure- 472
ments. Unlike bed or chair systems, where the subject stays 473
generally still for the measurement, postural sway, or ambulation 474
can create unwanted peaks or distortion in the measured signals. 475
Motion artifact detection for standing BCG measurements was 476
accomplished using auxiliary sensors as noise references; then, 477
gating the BCG signal based on the detection of excessive noise 478
[76], [80]. In one study, the noise reference was an extra strain 479
gauge added to the scale to detect postural sway [76]. In another 480
study, the rms power of the electromyogram signal from the feet, 481
indicating the presence of increased muscle contractions due to 482
excessive movement, was used as a noise gate for the BCG [80]. 483
Pandia et al. presented preliminary methods for cancelling mo- 484
tion artifacts in SCG signals from walking subjects, improving 485
overall heartbeat detection [77]. Di Rienzo et al. used an au- 486
tomatic selection of movement-free data segments from daily 487
recordings of SCG signals from ambulant subjects, followed by 488
an ECG triggered ensemble averaging to reduce signal noise 489
[21]. This enabled, for the first time, the assessment of systolic 490
time interval profiles during normal daily living. 491
BCG measurements taken in a direction orthogonal to 492
the plane of the floor can potentially be corrupted by floor 493
vibrations—this can particularly pose a challenge for measure- 494
ments taken on a vehicle [62] or plane [81]. Walter et al. instru- 495
mented the seat of a car with an EMFi mat to measure the BCG, 496
aiming to use the information to monitor driver fitness [62]. 497
However, with the engine turned on, the BCG was corrupted 498
by vibration artifacts and rendered unusable. Inan et al. used 499
an auxiliary sensor for vibration detection and adaptive noise 500
cancellation to cancel floor vibration artifacts in the BCG mea- 501
surement [78]. In this study, high-quality BCG measurements 502
were successfully demonstrated from a subject standing on a 503
bus with the engine turned on and idling. Additionally, it was 504
observed that low-noise SCG waveforms could be obtained in a 505
subject sitting in the metro, while a train was going by, with the 506
above mentioned ensemble averaging approach [21]. 507
C. Signal Modeling 508
Modeling of SCG and BCG provides a tool to better un- 509
derstand the genesis of waves in these signals and to simulate 510
their morphological changes with different myocardial abnor- 511
malities. Modeling of BCG goes back to the early years of 512
ballistocardiographic research [79]. 513
In most BCG recording systems, the recording device is quite 514
small compared to the human body and the platform on which 515
it rests. It is also far away from the heart in most cases; thus, 516
IE
EE
Pr
oo
f
INAN et al.: BALLISTOCARDIOGRAPHY AND SEISMOCARDIOGRAPHY: A REVIEW OF RECENT ADVANCES 7
Fig. 3. Schematic showing the subject (with mass, ms ) and the BCG recording
system (with mass, mb ) coupled by a spring dashpot system.
TABLE II
DESCRIPTIONS OF VARIABLES FOR SIGNAL MODELING
Variable Description
Fi n t Internal forces
β Damping constant
y Displacement or (in subscript) indicating
head-to-foot direction
y˙ Velocity
y¨ Acceleration
D Spring constant
ms Mass of subject
mb Mass of recording device
the volume of the heart has been neglected in such models. The517
heart has been modeled like a point source providing the flow518
to the circulation system model [82]. Such a model is in accor-519
dance with the classical definition of BCG to be resulted through520
movement of center of gravity of the body and platform. On the521
contrary, in SCG the recording device (i.e., accelerometer) is522
near the heart and the volume of the heart cannot be neglected523
in any model dealing with SCG or any other precordial vibra-524
tion signal. Thus, except for some preliminary efforts [83] SCG525
modeling has not been pursued by many researchers, probably526
because of the complications associated with such a model.527
In ballistocardiographic research, one can study the events528
within human body that cause its movement in space, regard-529
less of the recording device or to study the properties of in-530
struments recording them and how their record relates to the531
movement originating them. Both of these two approaches are532
briefly introduced.533
1) Modeling the Recording Device: During the early years534
of ballistocardiographic research, several different instruments535
were used to measure BCGs, from beds hanging from the ceiling536
[84] to tables strongly coupled to ground [1]. These instruments537
were giving different records from the same normal subjects. So,538
efforts were made to model the effect of these instruments on539
BCG morphology. Limiting ourselves to the head–foot direction540
the equation giving the components along the y-axis (Fig. 3,541
variables defined in Table II) reads:542
(Fint)y − βy˙ −Dy = (ms + mb)y¨. (1)
After sorting and substituting (Fint)y into msy¨c (where y¨c is543
the acceleration of center of mass of body):544
(ms + mb)y¨ + βy˙ + Dy = ms y¨c . (2)
From the above equation, three different classic types of 545
BCGs can be conceived based on the fact that which terms on 546
the left side of the above equation can be neglected. The first is 547
(ms + mb)y¨ = ms y¨c (3)
which means that the movement of bed and body is proportional 548
to the movement of the center of gravity. A good approximation 549
of this special case is when the ballistocardiograph is weakly 550
coupled to the environment such as ultralow frequency BCG 551
(ULF-BCG) systems. 552
The second type is when: 553
y˙ =
ms
β
y¨c (4)
which represents Nickersons’s low-frequency (LF) BCG and 554
the third type is when: 555
y =
ms + mb
β
y¨c (5)
which refers to the situation when BCG is strongly coupled to 556
its environment, which were categorized under high-frequency 557
BCG (HF-BCG). In other words, when the resonance frequency 558
of the BCG platform is much higher than heart frequency, then 559
its displacement is proportional to the internal acceleration of 560
body’s center of gravity. 561
From this theoretical evaluation, it is clear that very different 562
results will be obtained when one records any one aspect of 563
motion such as displacement or acceleration from each of the 564
three ideal types of ballistocardiographs [82]. However, there is 565
a fourth category of classical BCGs, which are the direct body 566
recordings based on AHA consensus paper on BCG terminol- 567
ogy [85]. Direct body BCGs were always criticized for their 568
inconsistencies [82]. 569
2) Modeling the Internal Forces: Starr started on BCG mod- 570
eling, where arteries were segmented into 3-cm long pieces and 571
mass of blood in the aortic segment closest to the aortic valve 572
was multiplied by acceleration, derived from cardiac ejection 573
curve, to calculate force. This was repeated when the blood 574
volume shifted to the next segment [82]. 575
A more comprehensive model of human systemic arterial 576
tree with distributed properties was constructed in early 1960s 577
by Starr and Noordergraaf [82] and was improved later on by 578
Westerhof et al. [86]. This model was based on the fact that, 579
when using ULF systems, in which the body was free to move in 580
space in the head–foot axis, it was observed that the body moved 581
first footward and then headward during the cardiac cycle. This 582
was explained as a movement to counteract the displacement of 583
the blood mass, that, shortly after the onset of systole, is first 584
driven headward out of the heart to distend the great vessels, 585
and later footward, as the pulse wave spreads peripherally and 586
blood accumulates at a great distance from the heart in the more 587
peripheral vessels. 588
The model divided the arterial tree in 115 segments and cal- 589
culated the position of the body’s center of gravity in the lon- 590
gitudinal direction yc(t), as a function of time, by numerical 591
integration of the products of the excess masses of each segment 592
during the interval t, and the distance yi between the centre of 593
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each segment and the reference plane. Noordergraaf’s model594
was successful in quantitatively predicting the amplitudes of595
ULF BCG waves and in giving an explanation for the origin of596
the main peaks. The model was verified on the data acquired597
from an astronaut in MIR station [87], where by using the lon-598
gitudinal BCG recorded in space the model could be used to599
derive the aortic flow.600
V. HUMAN SUBJECTS STUDIES WITH MODERN SYSTEMS601
A. Correlation Studies With Healthy Subjects602
Originally, BCG and SCG were proposed as diagnostic tools603
for the clinic—for example, a patient would lie on a Starr BCG604
table, the recording would be printed on a strip chart, and the605
physician would read the recording to make a diagnosis regard-606
ing the patient’s cardiovascular health [1], [5]. However, the607
large intersubject variability in the signals hampered this ap-608
proach, particularly given the limited tools available at that time609
for signal analysis. On the contrary, studies have shown that the610
intrasubject variability in the signals over serial measurements611
is actually low [15]—except in the presence of changing cardio-612
vascular health. For this reason, in the past decade the BCG and613
SCG have been proposed as tools for monitoring changes in the614
same patient’s health overtime. Then, the subject is his/her own615
control, and intersubject variability is no longer an obstacle.616
To uncover the clinical relevance of BCG and SCG signal fea-617
tures, and to pave the way for future studies with clinical popula-618
tions, several researchers conducted human subjects studies with619
a healthy population using modern instrumentation and analysis620
tools. These studies were mainly designed with a noninvasive621
protocol for altering the hemodynamics and timing intervals of622
the heart—such as exercise, Valsalva maneuver, whole-body tilt623
testing, or lower body negative pressure (LBNP)—then, com-624
paring the changes in the BCG or SCG waveform to changes in625
a reference standard measurement, such as impedance cardiog-626
raphy (ICG) or Doppler ultrasound.627
For both BCG and SCG signals the amplitude (or rms power)628
components have been shown to modulate with changes in left629
ventricular function—in particular, changes in stroke volume630
(SV) or cardiac output (CO). Castiglioni et al. measured clav-631
icular SCG signals before and immediately after exercise and632
compared the percent changes in the peak-to-peak amplitude of633
the SCG to changes in CO as measured by the finometer model634
flow method, finding a strong correlation for four data points635
taken from four subjects [24]. Inan et al. further demonstrated636
that the changes in rms power resulting from exercise, mea-637
sured during 10 min of recovery time, were strongly correlated638
to changes in CO measured by Doppler ultrasound for 275 data639
points taken from nine subjects [88]. Tavakolian etal. trained a640
neural network to estimate SV from SCG parameters and tested641
this classifier on a separate testing dataset, finding an average642
correlation coefficient of 0.61, and Bland–Altman agreement643
limits (95% confidence) of +7.4mL, −7.6mL for 4900 heart-644
beats analyzed from eight participants [16]. It is important to645
note that these error bands are larger than what would be needed646
for absolute volume estimation using the SCG; however, this647
may be of interest for future research.648
Many researchers have also examined the time intervals both 649
within the signals themselves, and between BCG / SCG sig- 650
nal features and other physiological measurements (e.g., ECG 651
or PPG), to form a relationship between these timing inter- 652
vals to more well-known parameters [e.g., preejection period 653
(PEP), pulse transit time (PTT), or left ventricular ejection time 654
(LVET)]. The time interval between the ECG R-wave peak and 655
the BCG J-wave peak has been proposed as a surrogate for the 656
PEP—a measure of the IVC period of the heart and an index of 657
cardiac contractility [30], [89]. These authors used the Valsalva 658
maneuver and/or whole body tilt testing to modulate the PEP 659
by changing the autonomic balance between parasympathetic 660
and sympathetic drive, and compared the R-J interval to the 661
PEP measured using ICG. Etemadi et al. demonstrated a strong 662
correlation (R2 = 0.86) between the R-J interval and the PEP 663
for 2126 heartbeats across ten subjects performing the Valsalva 664
maneuver [89]. He et al. showed similar results for one example 665
subject with both the Valsalva maneuver and whole-body tilt 666
testing [30]. Tavakolian etal. proposed the interval between the 667
ECG Q-wave and the SCG AO-point as a surrogate for PEP, and 668
found strong correlation between this interval and PEP measure- 669
ment using ICG and Doppler ultrasound in 25 subjects [16]. 670
Researchers have also attempted to extract data from the BCG 671
relating to blood pressure (BP), leveraging the known relation- 672
ship between pulse wave velocity estimated using PTT, and 673
Pinheiro et al. suggested the use of BCG and PPG for PTT esti- 674
mation [90]. Shin et al. compared the R-J interval of the BCG, 675
modulated using the Valsalva maneuver, to beat-by-beat sys- 676
tolic BP (SBP) measurements taken using the Finapres system, 677
finding a strong correlation [39]. Nevertheless, Casanella et al. 678
found that, in case of hemodynamic changes induced by paced 679
respiration, this correlation between R-J interval and SBP was 680
dependent on the subject and was not always observed [91]. 681
Winokur et al. found, for one example subject, that the time 682
interval between the BCG and the PPG signal, both measured 683
at the ear, were correlated to PTT, and could thus be used to 684
estimate BP [31]. 685
Another important interval is the duration of systolic ejection, 686
the LVET, as it provides an indication of what percentage of the 687
cardiac cycle is being devoted to ejection compared to filling. 688
Tavakolian et al. used LBNP to simulate hemorrhage, and found 689
that LVET measurements taken using SCG were significantly 690
different at various stages of LBNP, and correlates with the 691
LBNP levels (R = 0.90) for 32 subjects [92]. Di Rienzo et al. 692
found that with exercise LVET changes measured using wear- 693
able SCG are in line with the changes reported in the literature 694
and obtained by traditional laboratory techniques [21], [93]. 695
B. Clinical Findings From Patients 696
With Cardiovascular Disease 697
Modern ballistocardiography and seismocardiography sys- 698
tems may be capable of monitoring slow, longitudinal changes 699
in cardiac function associated with a number of cardiovascu- 700
lar diseases. Timely noninvasive detection of subtle changes in 701
cardiac pathophysiology may one day enable daily drug dosage 702
adjustments, thus reducing costly and morbid rehospitalizations 703
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[94]. At this moment, the feasibility of this approach is investi-704
gated by the ongoing LAPTOP-HF study which, however, uses705
an implantable right atrial pressure sensor coupled to a mobile706
device that allows daily automatic dosage adjustment [95].707
Fortunately, the basis for the SCG’s clinical utility was begun708
in 1990 with the initial use of high sensitivity, LF accelerometers709
to measure precordial vibrations [96]. Significant features of the710
SCG waveform were identified and associated with key events711
in the cardiac cycle [17]. This allowed the accurate measurement712
of these features (e.g., ACs and MOs) using one sensor, greatly713
simplifying the calculation of CTIs.714
A large body of work exists on the utility and efficacy of715
CTIs [97], [98]. This knowledge combined with the ability to716
make accurate, repeatable quantitative measurements using the717
SCG resulted in the ability to conduct clinically relavent cross-718
sectional studies. Subsequently, clinical studies were undertaken719
to determine if the SCG could be used to identify changes in the720
SCG waveform resulting from myocardial ischemia [99].721
The SCG’s clinical utility in enhancing the diagnostic out-722
come of a graded exercise stress test was first shown in [100]. A723
large multicenter study demonstrated that when the combined724
results of the ECG and SCG were used, the predictive accuracy725
of detecting physiologically significant coronary artery disease726
was increased significantly over the results of the ECG alone [7].727
The introduction in the early 1990s of lightweight (<25g)728
accelerometers, whose working range extended below 1 Hz,729
made possible other clinical settings for the SCG. The SCG730
as a magnetic-field-compatible alternative to the electrocardio-731
gram for cardiac stress monitoring [101] was made possible732
using a newly introduced light weight piezoelectric accelerom-733
eter (336C, PCB Piezotronics, Depew, NY, USA).734
The SCG was used to measure CTI’s during atrial, ventricular,735
and biventricular pacing, as compared to normals [102]. One of736
the studies objectives was to determine the utility of the SCG737
in cardiac resynchronization therapy (CRT). This study was the738
first to use 3 SCG traces for analysis, i.e., one accelerometer739
was placed on the xyphoid process, a second over the apex at740
the fourth intercostal, and a third on the right carotid pulse.741
In 1994, the SCG was used to make accurate longitudinal742
measurements in a study of the effects of elgodiphine on cardiac743
hemodynamics [103]. In a sports medicine application, exercise744
capacity was evaluated using the SCG [104]. A more extensive745
review of the SCG is available in [105].746
As a note of interest, the combined patient population of747
the myocardial ischemia studies [7], [100] is close to 2000748
and consists of both healthy and disease subjects. All the raw749
data were recorded with the same instrumentation (SCG 2000,750
SeisMed Instruments, Minneapolis, MN, USA) associated with751
these datasets are complete patient demographics. A project752
is underway to make the raw data available on the PhysioNet753
website for study by interested researchers [105].754
More recent findings with BCG and SCG further support that755
the signals have great potential in allowing proactive cardiac756
disease management without a costly implantable device. How-757
ever, despite stated clinical and/or physiologic motivations, the758
overwhelming majority of modern BCG/SCG findings continue759
to be from healthy subjects [106]–[108]. Notable exceptions in-760
clude a bed-mounted BCG system for automated detection of 761
atrial fibrillation [109], the observation of reduced signal ampli- 762
tude in the setting of premature atrial or ventricular contractions 763
[15], and the reduction of signal consistency in heart failure 764
patients concordant with worsening clinical outcome [110]. 765
One particular subset of patients is particularly well suited for 766
study using cardiomechanical signals, those undergoing CRT. 767
CRT patients have abnormal cardiac conduction causing in a 768
significant delay between the pumping action of the various 769
chambers of the heart. CRT involves precisely adjusting the 770
timing of a multichamber pacemaker to reduce or remove these 771
delays. Such timing is difficult to ascertain using available tech- 772
nologies, spawning the field of “CRT optimization.” Researchers 773
recently demonstrated the benefits of intracardiac acceleration 774
monitoring in performing CRT optimization [111], a finding 775
preliminarily corroborated by BCG findings as well [8]. 776
C. 3-D Ballistocardiography and Microgravity Studies 777
As the sections on instrumentation earlier in this review have 778
indicated, measurements of BCG (in particular) are constrained 779
by the coupling of the body to the ground, a direct result of the 780
influence of gravity. As such, full 3-D recordings of the BCG 781
are difficult in the terrestrial environment, and much of the focus 782
has been on accelerations in the coronal plane (the XY plane as 783
defined in the section on measurement axes). 784
Given this limitation, it is therefore not surprising that the 785
idea of measuring the BCG in a subject in free-fall (weightless- 786
ness, zero-G, microgravity) was an obvious target of investiga- 787
tion. The first such experiment was performed in the 1960s in 788
parabolic flight, with the subject strapped into a “tub,” which 789
was itself instrumented to record the BCG [9]. Despite the lim- 790
ited periods of microgravity available (typically 20 s) and the 791
subject restraints, recordings of good quality were obtained. 792
Spaceflight represents the other obvious environment in 793
which the “true” 3-D BCG can be recorded. The earliest record- 794
ings were made by the Soviets on Saluyt-6 [10] and consisted of 795
a series of five recordings were performed in two crew members 796
of a long duration mission on days 46, 71, 98, 133, and 175. 797
A piezoelectric sensor, attached close to the center of mass, 798
recorded ballistic forces in the feet-to-head axis during breath 799
holding experiments. Individual changes were seen during the 800
mission with maximum amplitude of the IJ wave occurring on 801
day 133. Measurements were also made during the Spacelab-1 802
mission aboard the Space Shuttle in 1983 [112]. These exper- 803
iments were conducted in two subjects at two occasions dur- 804
ing this short duration spaceflight and showed an increase of 805
the overall systolic accelerations along the longitudinal axis in 806
microgravity. 807
Perhaps the best-analyzed dataset of the BCG in spaceflight 808
came from measurements made during the Spacelab D-2 mis- 809
sion in 1993. During that flight, extra time became available (due 810
to an extension of the overall mission length), and an experiment 811
was hastily conceived, approved, implemented, and performed 812
to measure 3-D BCG in a free-floating subject. Parenthetically, 813
this may be one of the fastest spaceflight experiments ever de- 814
veloped with the time from concept, to collection of the data 815
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Fig. 4. Subject in D-2 shown wearing the snuggly-fitting suit incorporating a
respiratory inductance plethysmograph and ECG. Photo Credit: NASA.
(including approval of an institutional review board) was only816
4–5 days, surely some sort of record. The experiment utilized817
data from a free-floating subject instrumented with an ECG818
and wearing a snuggly fitting suit that measured respiratory819
motion using an impedance plethysmograph (see Fig. 4). This820
instrumentation was a part of the Anthrorack series of human821
studies managed by the European Space Agency. The second822
cruicial piece of instrumentation was a set of high-fidelity tri-823
axial accelerometer that were attached to the vehicle and used824
for measuring the accelerations imparted by crew activity in825
the Spacelab. The sensor package was detached from the ve-826
hicle and taped to the lumbar region of the subject, near to827
the (presumed) center of mass. Data were then recorded as828
the subject remained stationary and free floated in the center829
of the Spacelab, providing a continuous recording, free of in-830
terruptions of 146 s. In order to synchronize the two separate831
data streams, collisions with the Spacelab structure, which dis-832
rupted signals in both data streams, were used as posthoc event833
source [11].834
The data from the D-2 study and some subsequent studies835
provided valuable insight into several aspects of the BCG. In836
particular there were four major conclusions derived from this837
dataset.838
1) Lung volume greatly influences the accelerations839
recorded, especially in the longitudinal (head-to-foot)840
body axis (see Fig. 5), with the implication being that841
there is better coupling between the heart and the body in842
the longitudinal axis at higher lung volumes [11]. Inter-843
estingly, the actual direction of respiratory motion (mid844
inspiration versus mid expiration) had only minimal in-845
fluence of the BCG.846
2) Data derived from short periods of microgravity in847
parabolic flight are largely equivalent to data obtained848
in sustained microgravity [113].849
3) The BCG has a plane of symmetry that is primarily sagit-850
tal. This suggests that 2-D recordings performed in a851
supine subject (i.e., coronal recordings) fail to capture852
a significant portion of the effect of the blood ejection on853
the body, complicating their interpretation [113].854
Fig. 5. The 3-D BCG recorded in spaceflight in a free-floating subject, at the
end of a normal expiration (dashed lines, functional residual capacity, FRC), and
at the end of a normal inspiration (solid lines, FRC + tidal volume). From [11].
4) The accelerations that are recording in a 2-D system are 855
only modestly correlated with the true 3-D accelerations 856
that actually occur, again complicating their interpretation 857
[113]. 858
BCG flight experiments were also an integral part of the 859
Russian cardiovascular research program for the orbital sta- 860
tion MIR. BCG along the head-to-foot direction was measured 861
in three crew members during the second MIR mission in 862
1988 and compared to SCG recordings. Significant changes 863
of the BCG amplitudes (HI, IJ, JK) during the long-term flight 864
were described together with large inter individual differences. 865
The first true 3-D-BCG recordings were made during the sixth 866
MIR mission in 1990 in two crew members on flight days 56 867
and 110. Three new piezoelectric sensors were used placed 868
in perpendicular planes in a small cylindrical box with a di- 869
ameter of 40 mm and a height of 20 mm. The sensitivity of 870
the sensor was 20 mV/m/s2. The sensor was placed between 871
the scapulae using rubber belts and a metallic plate. The spe- 872
cial amplifier (BCG-3) was connected to the recording unit 873
“Gamma-1,” and the data were transmitted telemetrically to 874
the ground station. In summary, no dramatic changes in the vec- 875
tor sum were detected. Maximum forces ranged from 5.85 to 876
10.18 N. However, profound individual changes of the shape, 877
amplitude, and timing of the BCG, especially in the lateral 878
and dorso–ventral plane have been found. Finally, combined 879
BCG and SCG measurements have been made every month 880
in space during the 14 months space flight of Valeri Poljakov, 881
IE
EE
Pr
oo
f
INAN et al.: BALLISTOCARDIOGRAPHY AND SEISMOCARDIOGRAPHY: A REVIEW OF RECENT ADVANCES 11
15th to 17th MIR missions (Russian–Austrian flight experiment882
“Pulstrans”) [114].883
VI. STANDARDS AND OPEN ISSUES884
A. Need For a Standardization885
From the analysis of the literature, it appears that important886
methodological aspects concerning BCG and SCG analysis are887
still characterized by a certain level of ambiguity. These include888
1) Definitions of BCG and SCG Signals: In the literature, the889
definition of BCG and SCG is not univocal and the “BCG” term890
is even sometimes used for SCG signals.891
2) Nomenclature: Since BCG and SCG waveforms are892
mostly different (although they might have some common fea-893
tures to be investigated) it is reasonable to use a specific nomen-894
clature for defining peaks and valleys of each signal. The preva-895
lent annotation for BCG was proposed by Starr et al. [1], for896
SCG by Crow et al. [17]. However, there are some disagree-897
ments on these annotations, and in some instances, SCG peaks898
are termed with the BCG annotation.899
3) Indication of Site of Measurement, Characteristics of sen-900
sor, Sensor Axis Orientation: These pieces of information are901
crucial for data comparison and interpretation, but unfortunately902
are not invariably reported in scientific communications.903
A standardization or at least a common position on the above904
issues would greatly facilitate the understanding and comparison905
of published results, the exchange of data, and the design of new906
experimental protocols in this area.907
B. Open Issues908
A number of open issues remain to be addressed in this field to909
improve the understanding and applicability of BCG and SCG910
signals. Hereafter, we provide just a short list of these issues.911
1) The biological meaning of BCG and SCG deflections not912
yet annotated and their clinical relevance.913
2) Possible common features of the BCG and SCG signals.914
3) Further parameters derivable from the analysis of the BCG915
and SCG 3-D vectors.916
4) Effects of respiration, posture, right ventricle, and sensor917
adherence on the signal waveform/quality.918
5) How to facilitate the use of these signals in clinical prac-919
tice?920
6) Reference values for healthy and diseased subjects for921
both types of signals, and for a wide range of body922
types/sizes, and ages.923
VII. CONCLUSION AND AREAS FOR FUTURE INVESTIGATION924
The recent advances in the BCG and SCG field indicate the925
strong potential of these measurements to address wide vari-926
ety of clinical needs, in particular monitoring or trending the927
cardiomechanical health of patients outside of the clinic. Both928
BCG and SCG measurements can be taken using inexpensive929
and unobtrusive sensors, making them ideally suited, for exam-930
ple, for home monitoring of chronic diseases. Nevertheless, to931
maximize our ability to interpret these signals, the physiological932
origins of both signals must be studied further and elucidated. 933
Furthermore, there is a need to be able to map each measure- 934
ment modality to another using cardiovascular and mechanical 935
modeling of the body, such that any BCG or SCG waveform 936
amplitude, timing, or morphology measured using one modal- 937
ity can be translated quantitatively to another. For example, 938
if a bed-based recording in the dorso–ventral axis yielded a 939
peak BCG J-wave amplitude of 2 N, system modeling tools are 940
needed to compare this to a corresponding J-wave amplitude 941
measured using a weighing scale. Finally, an extensive, open 942
database of BCG and SCG signals, processing tools, and even 943
microprocessor code needs to be made available to massively 944
expand the capability of researchers around the world to inves- 945
tigate these signals, use them in their own settings, and grow the 946
field from a niche into an established technique, routinely used 947
in clinical practice. 948
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